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Abstract 
Development of Three-Compartment Breast Imaging for Clinical 
Applications in Dual Energy X-ray Absorptiometry 
by 
Jesus Ismael Avila 
Problem 
Approximately 75% of the breast cancer biopsies performed after 
recommendations from diagnostic mammography are benign, making it clear that 
specificity for diagnostic mammography still needs significant improvements. A novel 
three-compartment breast (3CB) composition technique developed by Laidevant et al. 
seeks to improve the specificity of diagnostic digital mammography, but it is prone to 
estimate incorrect compositional estimates for patient lesions. The focus of this thesis 
was to further develop this three-compartment technique for clinical applications in dual-
energy X-ray imaging modalities.  
Methods 
Three potential sources of error in the 3CB technique were studied: (1) 
attenuation coefficient differences in biological materials—for which 3CB is estimating 
compositional estimates—and their calibration equivalents, (2) nonuniformities in full-
field digital mammography (FFDM) from X-ray source spectra, and (3) initial intensity 𝐼଴ 
differences between biological and calibration images.  Initial developments for 3CB 
applications in digital breast tomosynthesis were also investigated, and these were in 
two areas: (1) dose measurements and estimates were made for high energy 3CB 
digital breast tomosynthesis (DBT) images and (2) derivation of potential variables of 
interest as predictors of breast thickness from raw DBT projections. Lastly, a novel 
technique for measuring body composition from 2D optical images to help monitor and 
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maintain healthy body weight was investigated, which could potentially aid in monitoring 
adipose and muscular tissues to monitor and maintain a lean weight to reduce risk of 
cancer for postmenopausal women in low-resource settings. 
Results 
To reduce error in the attenuation coefficient differences between biological and 
calibration materials, linear mappings were created using bovine and chicken 
phantoms. This linear mapping corrected negative 3CB compositional estimates in a 
population study. To reduce error in nonuniformities in FFDM source spectra, 
polynomial flat-fielding models were created. These reduced nonuniformities to at or 
below imaging noise levels.  To reduce 𝐼଴ differences between biological and calibration 
images, two 𝐼଴ correction models made it possible to obtain similar log-signal values 
between breast and calibration images.  
To make the 3CB applicable to DBT, two areas were investigated.  Firstly, dose 
measurements and estimates were made for HE 3CB DBT images.  It was found that a 
copper filter of 0.4064 mm (16 mils) seems to be optimal in terms of meeting dose 
requirements, availability, and CNR. In addition, imaging at 71 mAs seems to optimize 
CNR while satisfying dose requirements. Secondly, investigations sought to derive 
potential variables of interest as predictors of breast thickness from raw DBT 
projections.  It was found that variables derived from sinograms could be potentially 
useful in estimating breast thickness from raw DBT projections. 
The last topic discussed in this thesis focused on developing a novel body 
composition technique from optical images.  This proof-of-concept study showed that it 
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may be possible to determine fat mass index, fat-free mass index, and percent-fat from 
2D optical images. 
Conclusion 
Two of the three major works in this study advanced the 3CB imaging technique 
to become more clinically practical in dual-energy absorptiometry applications.  The last 
focus of this thesis may make it easier to monitor body composition in low-resource 
settings. 
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Chapter 1 Background 
 
 
Breast Cancer 
 
Worldwide, breast cancer is the second leading cause of cancer deaths, 
accounting for 11.6% of total cancer deaths. An estimated 6.6 million people will die 
from breast cancer in 2018.[1] “There is no treatment,” an ancient Egyptian text dating 
to about 3000 B.C. says about the disease.[2] Details of surgical intervention were first 
documented in the 1st century AD by Leonides of Alexandria.[3] More treatment 
options—such as endocrine surgery[4], radiation, and chemotherapy—became 
available in the 20th century, ushering a better outlook for patients.[5] Today, the overall 
average five-year and ten-year survival rates for breast cancer in the USA are 91% and 
86%, respectively.[6] In the USA, breast cancer mortality has decreased from 32 per 
100,000 to 21 per 100,000 from 1975 to 2010. Along with these advancements, 
however, overdiagnosis has now become a topic of interest in recent years, and many 
challenges remain before the fight against breast cancer is considered finished.  
Breasts have milk-producing lobules that are interconnected through a tubular 
system of ducts. These lobules and ducts are embedded in the breast’s fatty tissue, and 
the ducts terminate at a reservoir just behind the nipple. Approximately 80% of breast 
cancers originate within the ducts and the remaining 20% within the lobules.[7] The 
precursor to breast cancer is thought to be an abnormal growth in either lobular or 
ductal cells, known as atypical hyperplasia. In a study published in 2007 that included 
over 9,000 women and 331 atypical hyperplasia cases, it was found that women who 
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have either atypical lobular hyperplasia or atypical ductal hyperplasia “have a lifetime 
risk of breast cancer that is about four times higher than that of women who don't have 
atypical hyperplasia.”[8] If this abnormal growth progresses, it can become invasive and 
affect normal human physiology, which can ultimately lead to death.  
Breast Cancer Screening with X-ray Mammography 
 
The first randomized prospective trial of breast cancer, and cancer in general, 
was conducted by the Health Insurance Plan of New York in 1963.[9] From this study 
and up until 2011, a total of more than 650,000 women have been part of several 
randomized prospective breast screening trials. Not without controversy, researchers 
have agreed that breast cancer screening reduces mortality for certain age groups 
(“15% for women aged 39-49 years, 14% for women aged 50-59, and 32% for women 
aged 60-69 years, with corresponding numbers needed to invite to screening to prevent 
1 breast cancer death of 1,904, 1,339, and 377, respectively”). These trials were made 
possible with the development of a new mammography technique—since prior 
techniques had yielded poor image quality—introduced by Robert Egan and his 
colleagues in 1960.[10] 
Today, breast cancer screening conducted by health care institutions is 
dependent on radiographic sources such as X-ray, ultrasound, and magnetic 
resonance. Though physical examination is also conducted, typical screening programs 
rely mostly on X-ray sources, because of the combination of its lower relative cost over 
MRI and higher specificity over ultrasound.[11] From 2015 data, over 65% of U.S. 
women aged 40 and over have had a mammogram within the past two years, and 
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approximately 22.6 million patients had a mammographic procedure within the past 
year.[12, 13] It is because of breast cancer’s complexity, as it is in other cancers, that 
fights against it have turned to early detection and diagnosis, hoping to stop before it 
metastasizes. According to the National Cancer Institute’s (NCI) Surveillance, 
Epidemiology, and End Results Program (SEER), the five-year survival rates for 
localized, regional (spread to regional lymph nodes), distant (cancer has metastasized) 
are 98.7%, 85.3%, and 27.0%, respectively. Today, X-ray screening mammography has 
become the standard of care. For women in the US, screening mammography is 
recommended to start at age 40 by the American College of Radiology (2010) and 
American College of Obstetricians and Gynecologists (2011).[14] Other major USA 
organizations recommend starting at either age 45 or 50. In other countries, this age is 
typically 50.[15]  
Limitations of X-ray Mammography 
 
As far as X-ray screening mammography performance, its sensitivity ranges from 
83% to 95%; its specificity ranges from 90% to 98%.[16] For diagnostic X-ray 
mammography, the sensitivity was 85.8% and specificity was 87.7%. Although it has 
high specificity, approximately 75% of women who undergo biopsies after an initial 
finding during diagnostic mammography are benign, making it clear that specificity for 
diagnostic mammography still needs significant improvements.[17] 
During a mammography exam, radiologist search for abnormalities in breast 
texture (e.g., spiculations), objects that resemble tumors, shape differences between 
the two breasts, and change in breast images over time.[18] Calcifications, or 
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microcalcifications, are often the only sign of breast cancer because tumors only have 
mild changes in the X-ray attenuation coefficient.[19] The X-ray attenuation coefficient 
of calcifications is higher, however, than fibroglandular and adipose tissues, so they 
appear bright in X-ray mammography images. Even so, it can be difficult to find 
microcalcifications in dense breast [20-22], reducing the sensitivity of mammography.  
Potential Solutions to Limitations 
 
To address some of the limitations of mammography, other imaging modalities 
and techniques have been used in conjunction with X-ray mammography. These are 
discussed here. 
Contrast-Enhanced Mammography 
 
Some advanced applications in digital X-ray mammography have sought to 
improve contrast between lesions and fibroglandular tissue. One such application is 
contrast-enhanced mammography (CEM). Contrast-enhanced techniques rely on the 
biological principle of tumoral angiogenesis.[23] Malignant vessels are more permeable 
to contrast agents, increasing contrast between tumors and their surrounding 
tissues.[24, 25] Iodine is used intravenously in all CEM techniques.[26] Although CEM 
techniques can have high sensitivity (pooled test sensitivity of 0.98, 95% CI: 0.96-1.00 
for contrast-enhanced spectral mammography), specificity is typically low (0.58, 95% CI: 
0.38 – 0.77). In addition to low specificity, another limitation to CEM techniques is 
adverse reactions to iodine, which can vary from renal impairment to life-threatening 
anaphylactic shock.[26, 27] 
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Magnetic Resonance Imaging and Ultrasound 
Some non-ionizing imaging modalities are used as supplements to digital X-ray 
mammography. Contrast-enhanced magnetic resonance Imaging (MRI) for diagnostic 
imaging has been shown to have 94% sensitivity.[28, 29] Moreover, “…annual 
screening with MRI and mammography using a BI-RADS score of 4 or 5 to define 
positivity is currently the most accurate means of screening women with a strong 
familial or genetic predisposition to breast cancer. Limitations of MRI, however, include 
high cost, low availability, and relatively low specificity.  
Ultrasonography has shown a higher sensitivity than mammography for 
diagnostic imaging, especially in high-density breasts.[30] In one study, diagnostic 
accuracy for digital mammography plus ultrasound was reported as 0.91 (95% CI, 0.84-
0.96), while this figure was 0.78 (95% CI, 0.67-0.87) for digital mammography alone.[31] 
While diagnostic accuracy improved, the number of false positives substantially 
increased as well.  
Breast CT and Tomosynthesis 
 
Computed tomography (CT) is an imaging modality that acquires projections of 
an object to reconstruct its corresponding 3D volume. Individual 2D image “slices” can 
be viewed along any axis of the reconstructed volume. Although CT has been used in 
clinical practice since the 1970s, the first clinical trials for breast CT (BCT) happened in 
the past decade. BCT allows detection of lesions that could otherwise go undetected 
because of masking from dense fibroglandular tissues. A 2017 review of initial clinical 
trials of breast CT in Europe found that non-contrast breast CT and contrast-enhanced 
breast CT “was superior to mammography for the visualization of breast masses, 
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especially in patients with dense breast tissue.[32] The reported dose for breast CT in 
the studies was comparable to X-ray mammography dose, a mean glandular dose 
(MGD) of 9.4 mGy (SD = 3.1 mGy) for breast CT and 16.9 mGy (SD = 6.9 mGy) for 
digital X-ray mammography, though the number of views taken for X-ray mammography 
ranged from 2 to 11 breast.[33] In another study by Seifert et al., the MGD was 10.7 
mGy (SD = 3.0 mGy) for breast CT and 9.7 mGy (SD = 5.3. mGy) for digital X-ray 
mammography. 
Digital breast tomosynthesis (DBT) has also seen increased research efforts in 
the past couple of decades, but it has garnered much more attention over BCT. DBT is 
similar to CT in that it creates a reconstructed volume by capturing X-ray projections 
across a sweep angle, but this sweep angle is typically smaller than 50°. This creates a 
pseudo-3D volume with individual “slices” in the z-direction (the axis perpendicular to 
the detector plane) but with blurred artifacts from objects outside the focal plane Studies 
have similar or improved sensitivity and specificity over digital X-ray mammography 
(see 3CB Tomosynthesis for more details about DBT). 
Dual-Energy X-ray Imaging 
Dual-energy techniques rely on acquiring low energy (LE) and high-energy (HE) 
images to either improve contrast between tissues or for compositional measurements. 
A study with dual-energy contrast-enhanced digital mammography (DE-CEDM) found 
that the sensitivity of digital mammography alone was 0.80 (standard error = 0.04) while 
digital mammography plus DE-CEDM had sensitivity of 0.93 (SE = 0.03). For specificity, 
these were 0.50 (SE = 0.06) for digital mammography alone and 0.56 (SE = 0.06) for 
digital mammography plus DE-CEDM.  
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Three-Compartment Compositional Imaging 
While the above imaging techniques have addressed some limitations of 
screening and diagnostic digital mammography, specificity still needs to be improved to 
reduce the number of unnecessary biopsies. One technique that has been developed 
recently uses a three-compartment model of the breast to determine breast composition 
and lesion characterization.[34] This novel technique resolves dual energy images, 
along with a third measurement of breast thickness, to create water, lipid, and protein 
thickness estimates at every pixel. This method is the focus of much of the rest of this 
dissertation. The long-term goal of this work is to improve the specificity of diagnostic 
digital mammography. While this technique can be easily adapted to diagnostic digital 
mammography scanners, many technical challenges exist. For example, initial 
estimates of lesion compositions sometimes yielded negative thickness estimates for 
the compartments, which is physically unreasonable. The focus of this dissertation is to 
further develop this three-compartment technique by addressing the errors needing to 
be resolved before clinical application of the method can be realized. 
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Chapter 2 Energy dependent considerations: measuring three 
components of tissue for cancer lesion quantification 
 
 
Introduction 
Measuring the mass or volume of a tissue while it is surrounded by similar tissues 
is a difficult problem for X-ray imaging methods. X-ray attenuation alone cannot isolate 
one tissue from another with similar characteristics. Edge detection allows for delineation 
but not the density or composition of the organ. Dual-energy X-ray tissue composition 
imaging techniques can quantify the unique composition of organs using the unique 
energy dependence of materials to enable separation of two masses in digital images. 
Examples of this technique include contrast-enhanced (CE) digital subtraction 
mammography[35], Dual-energy X-ray absorptiometry (DXA)[36], CE digital breast 
tomosynthesis[37], and dual-energy CT[38], which all operate on different X-ray peak 
energy bands. As Lehmann et al. mention, the physical phenomena that allow two 
materials to be solved using X-ray energies available in medical imaging are the 
photoelectric effect and Compton scattering.[39] Any material can be characterized by its 
photoelectric and Compton coefficients, 𝑎௣ and 𝑎௖. Compositional images can be made 
by calibrating phantoms that have similar or equivalent coefficients and solving for their 
thicknesses. High and low X-ray energy images are acquired to capture these 
phenomena, typically acquired at fixed X-ray tube voltages because the attenuation 
coefficients are energy dependent. However, there are situations where one may want to 
use arbitrary high and low X-ray energies. This introduces complexity and practical 
difficulty in solving for the two biological materials, such as a three compartment breast 
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technique developed by Laidevant et al.[34, 40] Here, we outline the general solutions for 
duel-energy compositional imaging, outline calibration issues for practical devices, and 
outline one solution to the problem of arbitrary X-ray energies. 
 
Monoenergetic Case 
The simplest case for dual energy imaging is the use of a single-energy photon 
sources such as radioactive materials with monoenergetic emission, and gadolinium (Gd) 
has been used in medical imaging applications. Gd is unique in that it outputs two 
monochromatic emissions, X and Y. Using a discriminator, one can acquire monoenergic 
attenuation signals simultaneously. Thus, all X-ray photons used for an image acquisition 
have the same energy. Concerning the composition of humans, water, lipid, and protein 
account for approximately 99% of the mass of many soft tissues.[41] Glycogen is mostly 
found in skeletal muscle and liver, and it accounts for approximately “1% and 2.2% of 
their respective wet weights in the form of glycogen.”[41-43] The remaining component, 
mineral ash, is mostly found in bone. It is often convenient, therefore, for certain X-ray 
compositional imaging techniques to assume that soft tissues are composed of only 
water, lipid, and protein. For a three-component material, the resulting intensity 𝐼 is 
 
𝐼 ൌ 𝐼଴𝑒ିሺఓభሺாబሻ௧భାఓమሺாబሻ௧మା ఓయሺாబሻ௧యሻ  Equation 2-1 
 
where 𝜇௜ 𝑓𝑜𝑟 𝑖 ൌ 1, 2, 3 is the linear attenuation coefficient for a particular material and is 
approximated by the equation 
 
𝜇௜ ൌ ൫𝑎௣௜𝑓௣ ൅ 𝑎௖௜𝑓௖൯𝜌௜,  Equation 2-2 
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where 𝜌௜ is the density of the material. As stated by Lehmann et al., “𝑎௣ and 𝑎௖ are 
characteristic constants of the material and 𝑓௣ and 𝑓௖ are the energy dependencies of 
photoelectric absorption and Compton scattering, respectively.” In the log-signal form, 
 
𝐴ሺ𝐸଴ሻ ൌ  െ ln ൬ 𝐼𝐼଴൰ ൌ 𝜇ଵሺ𝐸଴ሻ𝑡ଵ ൅ 𝜇ଶሺ𝐸଴ሻ𝑡ଶ ൅ 𝜇ଷሺ𝐸଴ሻ𝑡ଷ 
Equation 2-3 
 
The total thickness of the material 𝑇 is the sum of the component materials: 
 
𝑇 ൌ 𝑡ଵ ൅ 𝑡ଶ ൅ 𝑡ଷ Equation 2-4 
 
Individual component thicknesses can be solved by acquiring a low energy (mostly 
a photoelectric effect with some Compton scattering) and a high-energy image (captures 
less of the photoelectric effect and more Compton scattering) using a system of linear 
equations. In matrix form we get  
 
𝝁𝒕 ൌ 𝑨, where Equation 2-5 
 
 
𝝁 ൌ ቈ
𝜇ଵ,௅ா 𝜇ଶ,௅ா 𝜇ଷ ,௅ா𝜇ଵ,ுா 𝜇ଶ,ுா 𝜇ଷ,ுா
1 1 1
቉,  𝒕 ൌ ൥
𝑡ଵ𝑡ଶ𝑡ଷ
൩  ,  𝑨 ൌ ൥
𝐴௅ா𝐴ுா𝑇
൩ 
 
Solving for 𝒕 we get 
 
𝒕 ൌ 𝝁ି𝟏𝑨. Equation 2-6 
 
 
 
If the attenuation coefficient values are known for the materials and energies, 
then with the measurement of overall tissue thickness 𝑇 and LE and HE log-signals (𝐴௅ா 
and 𝐴ுா), the individual material thicknesses can be solved. However, the exact 
attenuation properties of tissue are often not known, and the attenuation coefficient 
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values need to be solved empirically. This is often using a calibration object with 
materials that represent the tissues of interests. The calibration materials are never the 
exact composition of the body tissues they represent and introduce errors in 
approximating the thickness of the body tissues. These errors, represented as 𝜖௣ and 𝜖௖ 
in the characteristic constants of a material, modify the attenuation coefficients in the 
following way:  
 
𝜇௜ᇱ ൌ ൫𝜖௣௜𝑎௣௜𝑓௣ ൅ 𝜖௖௜𝑎௖௜𝑓௖൯𝜌௜ Equation 2-7 
 
 
Since 𝜖௣௜ and 𝜖௖௜ are fixed for each calibration material and component pair, 𝜇௜ᇱ 
will also have a fixed total error 𝜖்௜ such that 𝜇௜ᇱ is a scaled version of 𝜇௜, i.e.  
 
𝑢௜ᇱ ൌ 𝜖்௜𝜇௜. Equation 2-8 
 
If the error 𝜖்௜ is known, then the correct thickness estimates for the biological 
materials can be solved using linear coefficients of the calibration materials, so having 
an error creates a linear transformation between the two material spaces (biological and 
calibration). Deriving the correct thicknesses for biological materials in the 
monoenergetic case is straightforward, but in practice, X-ray systems have 
polyenergetic X-ray tubes. X-ray tubes typically have both sharp emissions at particular 
energies such as k-shell edges, but the dominant emission is often from 
Bremsstrahlung radiation—created from electrons losing kinetic energy as they 
decelerate when near the nucleus of an atom—and have, from inception, varying 
energies.[44] In the next section, we expand Equation 2-7 to include polyenergetic X-ray 
sources.  
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Polyenergetic Case 
For the polyenergetic case, the entire spectrum must be considered; thus, our log-
signal function for LE and HE becomes 
 
𝐴௝ሺ𝐸ሻ ൌ െ 𝐼ሺ𝐸ሻ𝐼଴ሺ𝐸ሻ ൌ
׬ 𝐼଴ሺ𝐸ሻ𝑒ఓభሺாሻ௧భାఓమሺாሻ௧మା ఓయሺாሻ௧య 𝑑𝐸
׬ 𝐼଴ሺ𝐸ሻ𝑑𝐸  
Equation 2-9 
 
This cannot be solved analytically, but compartment thickness 𝑡௜ can be modeled by a 
nonlinear function of energy and total thickness.[34, 39, 45]  
𝑡௜  ൌ ∑ 𝑏ఈఉఊ,௜ 𝐴ுாఈ 𝑅ఉ𝑇ఊ ఈ,ఉ,ఊ,∈ ே  , where 
 
Equation 2-10 
𝑅 ൌ ஺ಽಶ஺ಹಶ is the ratio of log-signal functions of low and high energies, 𝑏ఈఉఊ,௜ is a coefficient of each term in the infinite series for each material 𝑖. 
 
For a quadratic solution (degree two), we have the following: 
 
𝑡௜ ൌ 𝑎ଵ,௜ ൅ 𝑎ଶ,௜𝐴ுா ൅ 𝑎ଷ,௜𝑅 ൅ 𝑎ସ,௜𝑇 ൅ 𝑎ହ,௜𝐴ுாଶ ൅ 𝑎଺,௜𝑅ଶ ൅ 𝑎଻,௜𝑇ଶ
൅ 𝑎଼,௜𝐴ுா𝑅 ൅ 𝑎ଽ,௜𝐴ுா𝑇 ൅ 𝑎ଵ଴,௜𝑅𝑇 
Equation 2-11 
 
Since the total thickness is known, one need only derive thicknesses—and thus the 
calibration coefficients 𝑏ఈఉఊ,௜—for two materials (and solve for the third algebraically).  
Each term in the polynomial that has 𝐴ுா or 𝑅 will have an error associated with 
material differences between biological and calibration materials, since these terms 
contain the linear attenuation coefficient 𝜇௜. The linear attenuation coefficient for the 
polyenergetic case is as follows: 
𝜇௜ሺ𝐸ሻ ൌ ൫𝑎௣௜𝑓௣ሺ𝐸ሻ ൅ 𝑎௖௜𝑓௖ሺ𝐸ሻ൯𝜌௜ Equation 2-12 
 
And it follows, for calibration materials, that  
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𝜇௜ᇱሺ𝐸ሻ ൌ ൫𝜖௣௜𝑎௣௜𝑓௣ሺ𝐸ሻ ൅ 𝜖௖௜𝑎௖௜𝑓௖ሺ𝐸ሻ൯𝜌௜ Equation 2-13 
 
It is important to note that although the errors 𝜖௣௜ and 𝜖௖௜ are still energy independent—
since the photoelectric and Compton coefficients 𝑎௣ and 𝑎௖ are energy independent—
the total error total error 𝜖்௜ is not; thus, we have  
𝜇௜ᇱሺ𝐸ሻ ൌ 𝜖்௜ሺ𝐸ሻ𝜇௜ሺ𝐸ሻ, where Equation 2-14 
 
𝜇௜ᇱሺ𝐸ሻ ൌ
൫𝜖௣௜𝑎௣௜𝑓௣ሺ𝐸ሻ ൅ 𝜖௖௜𝑎௖௜𝑓௖ሺ𝐸ሻ൯
൫𝑎௣௜𝑓௣ሺ𝐸ሻ ൅ 𝑎௖௜𝑓௖ሺ𝐸ሻ൯  𝜇௜ሺ𝐸ሻ 
 
 
This error, of course, affects the solution for each material thickness 𝑡௜. A map, 
therefore, is needed to transform incorrect material thickness values 𝑡௜ᇱ to 𝑡௜, such that 
  
 
𝑡௜ ൌ 𝑇ሾ𝑡௜ᇱሿ 
 
Though mapping has been performed for breast composition in dual-energy 
mammography for determining calcification thickness and glandular ratio by Kappadath 
and Shaw, only two materials were considered.[46]  
Polyenergetic Case and Varying kVp 
 
This case is similar to the polyenergetic one but with varying LE kVp acquisitions. 
For full-field digital mammography (FFDM) scanners, for example, images are typically 
acquired in the 24-32 kVp range. The map between the two material spaces would need 
to be made for each kVp that is used to minimize the error between material spaces. 
Recently, Laidevant et al. developed a dual energy X-ray imaging method that uses a 
three-compartment breast model (3CB) to characterize tissue composition.[47] The 3CB 
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method represents breast tissue as the equivalent composition of the phantom 
materials—Delrin, Plastic Water®, and machinable wax. The 3CB model is derived by 
acquiring three measurements: a low-energy image, a high-energy image, and the total 
thickness of the breast at each pixel. By generating images of the water, lipid, and protein 
(WLP) content of the breast, it may be possible to get a characteristic signature of 
malignant and benign lesions. Drukker et al. recently used this technique in conjunction 
with breast morphometry features for classifying lesions and found improved classification 
vs. either technique alone.[48] Additionally, Malkov et al. found compositional differences 
in lesion classifications.[49] 
 
Application 
 
The 3CB technique relies on calibration materials for biological equivalents of lipid, 
water, and protein. Though compositional estimates have been made for breasts using 
the 3CB technique, there were negative protein estimates. This could be attributed to 
errors described above, since the relationship between actual breast tissue 
compartments of lipid, water, and protein differ from the phantom. We have modeled in a 
previous study that the major source of error could be attributed to energy-dependent 
differences between the calibration materials and their biological equivalents.[50] In this 
study, we derive a calibration method to correct for thickness errors using a biological 
phantom. We validate this method with lipid and water experiments, and we test its effect 
by applying it to participant data. 
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Methods 
Population 
Participants were part of the “Lesion Composition and Quantitative Imaging 
Analysis on Breast Cancer Diagnosis” investigator-initiated study to characterize the 
composition of invasive breast cancer lesions (R01CA166945, PIs Shepherd/Giger). 
Participants were recruited from women undergoing breast biopsy (BIRADS 4 or 5) to 
have additional diagnostic imaging. Images of the participant were acquired before their 
biopsy procedure. The following exclusion criteria were used: prior breast cancer, prior 
breast interventions (e.g., previous breast biopsy), breast alterations, and 
mammographically occult findings. Study radiologists delineated the breast lesions on the 
LE craniocaudal and mediolateral oblique views. From these delineations, compositional 
measures were derived using the area inside the delineation and the immediate 
periphery.[51] This study was approved by UCSF’s Institutional Review Board. 
 
Oil & Water Validation Experiment 
The purpose of this experiment is to show if the 3CB technique is energy 
independent; if so, 3CB thickness estimates of a sample should be the same regardless 
of the kVp of the LE image. A blue wax step phantom was placed inside a container and 
filled with canola oil until the total thickness of the oil reached 30 mm. A similar procedure 
was done for Plastic Water® and distilled water. These containers represented the lipid 
and water compartments, respectively. Images were acquired at 27 kVp and 30 kVp for 
both containers. The 3CB method was applied to different ROIs in the images, which 
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represented 0, 33, 50, and 67 % calibration material and 100, 67, 50, and 33 % canola 
oil or distilled water.[52] 
 
3CB Images and Bovine Calibration 
Hologic (Hologic, Inc., Bedford, MA) full-field digital mammography scanners were 
used to acquire the LE and HE images. A thickness map of the breast was then derived 
using the single X-ray absorptiometry (SXA) phantom. The 3CB technique was then 
applied to derive the three compositional thickness images—lipid, water, and protein 
(Figure 2.1). A bovine-derived affine transformation was then applied to these thickness 
images to correct for calibration material differences. The transformation is applied as 
follows: 
 
ሾ𝑊ᇱ 𝐿ᇱ 𝑃ᇱሿ ൌ ሾ𝑊 𝐿 𝑃ሿ𝐵ሺ𝑘𝑉𝑃ሻ, where Equation 2-15 
 
 𝐵 ൌ  ൥
bଵଵ bଵଶ bଵଷ
bଶଵ bଶଶ bଶଷ
bଷଵ bଷଶ bଷଷ
൩,  
and 𝑊, 𝐿, and 𝑃 are initial water, lipid, and protein estimates from a 51-point calibration 
phantom. The elements 𝑏௜௝ of the affine transformation were derived using the least-
squares fit between ሾ𝑊ᇱ𝐿ᇱ𝑃ᇱሿ and ሾ𝑊 𝐿 𝑃ሿ from a bovine phantom of known composition.  
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Figure 2.1 The mammogram, water, lipid, and protein images of a breast sample are shown. These are derived 
using the 3CB method described above. The annotation outlined by a radiologist is also shown in each figure, 
along with three concentric regions spaced 2 mm apart. 
 
Phantoms 
SXA Phantom 
The SXA phantom was used to estimate the thickness of the breasts under 
compression, regardless of paddle tilt.[53] The phantom was placed near one of the 
corners of the field of view such that it would not interfere with the breast area in the 
image. A least-squares technique was used to locate the phantom and estimate paddle 
tilt, and from these a thickness map was generated for breasts at each pixel. 
 
51-Point Calibration Phantom 
This phantom contains the three calibration materials for lipid, water, and protein—
blue wax, Plastic Water®, and Delrin (Figure 2.2). This is the main 3CB calibration 
phantom, and it contains 51 unique WLP regions of interests (ROIs). This phantom is 
used to derive the calibration coefficients 𝑎ఈఉఊ,௜, and corresponding images are taken of 
the phantom for each breast that is imaged. The same imaging parameters as the breast 
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were used for the phantom LE and HE images. Most of the phantom was manufactured 
with fabrication tools in-lab, and a portion of it was fabricated by a local machine shop. 
 
Figure 2.2 The 51-point calibration phantom is shown on the left, and an X-ray projection of it is shown on 
the right. An X-ray projection of the SXA phantom is also shown on the right. 
Bovine and Chicken Phantoms 
The bovine and chicken phantoms had 15 ROIs. Bovine lean muscle and suet 
were combined into volumetric fractions of 0.0/1.0, 0.25/0.75, 0.5/0.5, 0.75/0.25, and 
1.0/0.0 for different ROIs. The total thickness for each “step” of the phantom was 2, 4, 
and 6 cm. As for the chicken phantom, LE images were acquired at varying kVp (25 – 32 
kVp) to match the energy levels of breast images. Samples were sent to Anresco 
Laboratories (San Francisco, CA) for chemical composition analyses.  
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Figure 2.3 The bovine phantom is shown on the left and its corresponding X-ray projection is shown on the right. 
This phantom was used to create a linear map between the 51-point CP and biological materials. 
 
 
Figure 2.4 The chicken phantom is shown on the left and its corresponding X-ray projection is shown on the right. 
Results 
Population Description 
The bovine correction was also applied to a set of participants. Demographics of 
these participants are shown in Table 2.1. One of the participants was removed since 
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no estimate could be created, so a total of 80/81 patients had compositional estimates 
created.  
Table 2.1 Demographics of study participants.  
   N  % 
Number of Women Imaged at each kVp     
  kVp = 25  4  4.94 
  kVp = 26  2  2.47 
  kVp = 27  5  6.17 
  kVp = 28  15  18.52 
  kVp = 29  7  8.64 
  kVp = 30  13  16.05 
  kVp = 31  8  9.88 
  kVp = 32  27  33.33 
  Total   81  100 
    
Breast Density     
  A=Almost entirely fatty  5  6.17 
  B=Scattered fibroglandular densities  29  35.8 
  C=Heterogeneously dense  39  48.15 
  D=Extremely dense  39  9.88 
  Total   81  100 
    
Age  53.91 ± 9.92 
    
Height  64.65 ± 2.74 
    
Weight  150.46 ± 31.6 
    
BMI  25.3 ± 5.13 
 
Corrections with Biological Phantoms 
The composition results of the bovine phantom samples are shown in Table 2.2 
and Table 2.3. Composition results for the chicken phantom are in Table 2.4 and Table 
2.5.  
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Table 2.2 Composition of Bovine Phantom tissue samples by % weight and volume 
Component 
Density 
used for 
Conversio
n (g/cm^3) 
Bovine 
Compositio
n by % 
Weight 
Bovine 
Compositio
n by % 
Volume 
Suet 
Compositio
n by % 
Weight 
Suet 
Compositio
n by % 
Volume 
Water 1 70.03 75.04 11.90 11.11 
Lipid 0.92 4.44 5.17 86.52 87.83 
Protein 1.35 24.50 19.45 1.50 1.04 
Mineral Ash 3.2 1.03 0.34 0.08 0.02 
 
Table 2.3 Bovine Phantom regions of interest compositions with estimated water, lipid, protein, and mineral ash components 
from laboratory analysis.  
Region 
of 
Interest 
Total ROI 
Thickness 
(mm) 
Percent 
Density (%)* 
Water 
thickness 
(mm) 
Lipid 
Thickness 
(mm) 
Protein 
Thickness 
(mm) 
Mineral Ash 
Thickness 
(mm) 
1  60.50  0.00  6.72  53.13  0.63  0.01 
2  40.20  0.00  4.47  35.31  0.42  0.01 
3  20.20  0.00  2.24  17.74  0.21  0.00 
4  60.50  21.49  15.03  42.39  3.02  0.06 
5  40.30  36.72  13.94  23.16  3.14  0.06 
6  20.20  34.65  6.72  11.95  1.50  0.03 
7  60.50  51.24  26.54  27.51  6.33  0.11 
8  40.20  53.23  18.15  17.62  4.36  0.08 
9  20.20  48.02  8.45  9.72  2.00  0.04 
10  60.50  100.00  45.40  3.13  11.76  0.21 
11  40.20  100.00  30.17  2.08  7.82  0.14 
12  20.20  100.00  15.16  1.04  3.93  0.07 
13  60.40  60.93  30.24  22.63  7.40  0.13 
14  40.20  64.68  21.09  13.82  5.20  0.09 
15  20.10  66.17  10.74  6.66  2.66  0.05 
  *Density is defined as the meat thickness/total thickness*100      
Table 2.4 Composition of Chicken Phantom tissue samples by % weight and volume 
Component 
Density 
used for 
Conversion 
(g/cm^3) 
Gallus 
Composition 
by % Weight 
Gallus 
Composition 
by % 
Volume 
Tallow 
Composition 
by % Weight 
Tallow 
Composition 
by % 
Volume 
Water  1  75.04  80.88  0  0 
Lipid  0.92*  0.06  0.07  100  100 
Protein  1.35  23.09  18.44  0  0 
Mineral Ash  3.2  1.81**  0.61  0  0 
*Although Tallow density = 0.87, this does not affect Tallow conversion since it is 100% lipid 
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**Mineral Ash content includes 0.63 % total carbohydrates     
Table 2.5 Chicken Phantom regions of interest compositions with estimated water, lipid, protein, and mineral ash components from 
laboratory analysis. 
Region of 
Interest 
Total ROI 
Thickness 
(mm) 
Percent 
Density 
(%)* 
Water 
thickness 
(mm) 
Lipid 
Thickness 
(mm) 
Protein 
Thickness 
(mm) 
Mineral 
Ash 
Thickness 
(mm) 
1 69.14 0.00 0.00 69.14 0.00 0.00 
2 48.77 0.00 0.00 48.77 0.00 0.00 
3 29.41 0.00 0.00 29.41 0.00 0.00 
4 69.14 75.20 42.05 17.18 9.59 0.32 
5 48.77 77.97 30.76 10.77 7.01 0.23 
6 29.41 67.27 16.00 9.64 3.65 0.12 
7 69.14 61.54 34.41 26.62 7.84 0.26 
8 48.77 51.30 20.24 23.77 4.61 0.15 
9 29.41 50.78 12.08 14.49 2.75 0.09 
10 69.14 100.00 55.92 0.05 12.75 0.42 
11 48.77 100.00 39.45 0.03 8.99 0.30 
12 29.41 100.00 23.79 0.02 5.42 0.18 
13 69.14 29.90 16.72 48.48 3.81 0.13 
14 48.77 29.17 11.50 34.55 2.62 0.09 
15 29.41 24.01 5.71 22.36 1.30 0.04 
 *Density is defined as the meat thickness/total thickness*100   
Figure 2.5 shows how different element values of the affine transformation 𝐵 vary 
as a function of kVp. By going through the matrix multiplication, we can observe how 𝐵 
maps the WLP vectors between the calibration material and bovine spaces. For 𝑊, the 
water vector, the corresponding elements that affect its transformation are b11, b21, 
and b31, yielding the new vector 𝑊ᇱ ൌ 𝑏ଵଵ𝑊 ൅ 𝑏ଶଵ𝐿 ൅ 𝑏ଷଵ𝑃. Figure 2.6 shows similar 
plots but for the chicken phantom. For the chicken phantom, it appears that most of the 
energy-dependent variation of the elements occur at the lower energy levels. 
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 Figure 2.5 This shows the different elements of the transfer function, a 3x3 matrix 𝑩, from calibration material 
space to bovine space as a function of kVp. Most of the elements are constant, but elements 𝒃𝟑𝟏, 𝒃𝟑𝟐, and 𝒃𝟑𝟑–which scale the protein vector 𝑷 in the matrix multiplication—vary as a function of kVp.  
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Figure 2.6 The chicken phantom transfer function components. This shows the different elements of the transfer 
function, a 3x3 matrix 𝑩, from calibration material space to chicken space as a function of kVp.  
 
Table 2.6 shows the equation form of the matrix multiplication. For the bovine 
phantom: for 𝑊′, the water contribution 𝑊 is reduced, 𝐿 doesn’t contribute, and protein 
contributes but to a lesser extent (since protein is about factor lower than 𝑊 and the 
range for 𝑏ଷଵis approximately 1.05 – 1.21). For 𝐿′, 𝑊 plays a contribution and is 
approximately constant, 𝐿 is almost the unit value, and 𝑃 is multiplied by a negative 
number (range of 𝑏ଷଶ is approximately -0.55 – -0.33). For 𝑃′, 𝑊is scaled at a similar 
value as the water contribution for 𝐿′ (~0.16), 𝐿 slightly contributes, and 𝑃 is also varies 
over the kVp range (range of 𝑏ଷଷ is approximately 0.28 – 0.33). In all three equations, 
protein seems to be the most energy dependent while the other components can be 
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replaced by constants. For the chicken phantom, the protein component 𝑃′ seems to be 
a constant equation for all kVps, while 𝑊ᇱ and 𝐿′ vary as a function of kVp. 
 
Table 2.6 The matrix multiplication for each input vector is shown.  
Input 
Vector 
3x3 Matrix  
Multiplications 
Bovine Multiplications 
(simplified form) 
Chicken Multiplications 
(simplified form) 
𝑊 𝑊ᇱ ൌ  𝑏ଵଵሺ𝑘𝑉𝑝ሻ𝑊 ൅ 𝑏ଶଵሺ𝑘𝑉𝑝ሻ𝐿 ൅ 𝑏ଷଵሺ𝑘𝑉𝑝ሻ𝑃 𝑊ᇱ ൎ 0.63𝑊 ൅ 0.0𝐿 ൅ 𝑏ଷଵሺ𝑘𝑉𝑝ሻ𝑃 𝑊ᇱ ൌ  𝑏ଵଵሺ𝑘𝑉𝑝ሻ𝑊 ൅ 𝑏ଶଵሺ𝑘𝑉𝑝ሻ𝐿 ൅ 𝑏ଷଵሺ𝑘𝑉𝑝ሻ𝑃 
𝐿 𝐿ᇱ ൌ  𝑏ଵଶሺ𝑘𝑉𝑝ሻ𝑊 ൅ 𝑏ଶଶሺ𝑘𝑉𝑝ሻ𝐿 ൅ 𝑏ଷଶሺ𝑘𝑉𝑝ሻ𝑃 𝐿ᇱ ൎ 0.24𝑊 ൅ 1.02𝐿 ൅ 𝑏ଷଶሺ𝑘𝑉𝑝ሻ𝑃 𝐿ᇱ ൌ  𝑏ଵଶሺ𝑘𝑉𝑝ሻ𝑊 ൅ 𝑏ଶଶሺ𝑘𝑉𝑝ሻ𝐿 ൅ 𝑏ଷଶሺ𝑘𝑉𝑝ሻ𝑃 
𝑃 𝑃ᇱ ൌ 𝑏ଵଷሺ𝑘𝑉𝑝ሻ𝑊 ൅ 𝑏ଶଷሺ𝑘𝑉𝑝ሻ𝐿 ൅ 𝑏ଷଷሺ𝑘𝑉𝑝ሻ𝑃 𝑃ᇱ ൎ 0.16𝑊 െ 0.02𝐿 ൅ 𝑏ଷଷሺ𝑘𝑉𝑝ሻ𝑃 𝑃ᇱ ൎ 0.15 ൅ 0.0𝐿 ൅ 0.29𝑃 
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Figure 2.7 Bovine phantom ROI water thickness estimates vs. actual for each kVp. The top shows the estimates 
using only the calibration phantom, and the bottom plot shows estimates after a linear correction (3x3 matrix) was 
applied using data from the top plot. 
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Figure 2.8 Bovine phantom ROI lipid thickness estimates vs. actual for each kVp. The top shows the estimates using 
only the calibration phantom, and the bottom plot shows estimates after a linear correction (3x3 matrix) was applied 
using data from the top plot. 
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Figure 2.9 Bovine phantom ROI protein thickness estimates vs. actual for each kVp. The top shows the estimates 
using only the calibration phantom, and the bottom plot shows estimates after a linear correction (3x3 matrix) was 
applied using data from the top plot. 
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Figure 2.10 Chicken phantom ROI water thickness estimates vs. actual for each kVp. The top shows the estimates 
using only the calibration phantom, and the bottom plot shows estimates after a linear correction (3x3 matrix) was 
applied using data from the top plot. 
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Figure 2.11 Chicken phantom ROI water thickness estimates vs. actual for each kVp. The top shows the estimates 
using only the calibration phantom, and the bottom plot shows estimates after a linear correction (3x3 matrix) was 
applied using data from the top plot. 
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Figure 2.12 Chicken phantom ROI water thickness estimates vs. actual for each kVp. The top shows the estimates 
using only the calibration phantom, and the bottom plot shows estimates after a linear correction (3x3 matrix) was 
applied using data from the top plot. 
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Figure 2.13, Figure 2.14, and Figure 2.15 show the percent errors of the 15 
regions of interest (ROIs) of the bovine phantom before and after applying the transfer 
function. The top plot shows the percent error before the bovine correction/transfer 
function was applied, and the bottom shows the estimates after the bovine correction 
was applied.  
 
% 𝐸𝑟𝑟𝑜𝑟 ൌ 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 ሺ𝑅𝑃𝐷ሻ ൌ  2 ∗ ሺ3𝐶𝐵 𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 െ 𝐿𝑎𝑏 𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒ሻ|3𝐶𝐵 𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒| ൅ |𝐿𝑎𝑏 𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒| ∗ 100, 𝑤ℎ𝑒𝑟𝑒 
𝑅𝑃𝐷 ൌ 0 𝑤ℎ𝑒𝑛 3𝐶𝐵 𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 ൌ 𝐿𝑎𝑏 𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 ൌ 0 
 
The RPD was used over percent difference to avoid dividing by zero. The 𝐿𝑎𝑏 𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 
is the computed estimate based on laboratory results of tissue samples. 
 
Figure 2.13 The 3CB water thickness estimate for the fifteen ROIs of the bovine phantom are shown before 
and after linear correction was applied. 
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Figure 2.14 The 3CB lipid thickness estimate for the fifteen ROIs of the bovine phantom are shown before and 
after linear correction was applied. 
 
Figure 2.15 The 3CB protein thickness estimate for the fifteen ROIs of the bovine phantom are shown before 
and after linear correction was applied. 
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Oil Experiments 
The results for the oil experiment are shown in Figure 2.16. The affine 
transformation seemed to correct the thickness estimate error between the two energy 
levels, though it did not correctly estimate the measured 30 mm thickness. For each 
boxplot, “the central mark is the median, the edges of the box are the 25th and 75th 
percentiles, the whiskers extend to the most extreme datapoints the algorithm considers 
to be not outliers, and the outliers are plotted individually” (MATLAB, 2016b). The top 
plot shows the estimated lipid thicknesses pre-bovine correction. Regions of interest on 
the oil images are compared between two different LE levels, 27 and 30 kVp. There are 
significant differences (p < 0.001 for all comparisons) in the estimated lipid thickness 
between the two energy levels for all ROIs. After the bovine correction is applied 
(bottom plot), there still seem to be significant differences between the two energy 
levels. Moreover, there is still an approximately 16% error between the actual and 
estimated lipid thickness (30 mm vs. 25 mm, respectively). A similar figure can be seen 
for the water experiment, but the error is larger between actual and estimated (~40 %). 
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Figure 2.16 The estimated lipid thicknesses for different regions of interest (ROIs), pre- and post-bovine 
correction.  
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Population Corrections 
 
Figure 2.17 shows patient data thickness estimates before and after models were 
applied. The top figure shows these distributions for pre- and post-bovine correction 
estimate, and the bottom for the chicken model. The mean, standard deviation, 
minimum thickness, and maximum thickness for pre- and post-model corrections are 
shown for all distributions. For both models, the lipid compartment distribution seemed 
to shift toward the right, indicating that the 3CB calibration phantom was 
underestimating lipid thicknesses. For water distributions in both models, the post-
model correction narrowed and shifted the distribution to the left, which indicates that 
the 3CB calibration phantom was overestimating the water compartment. This 
overestimation seems to have caused negative protein estimates in the distributions of 
both models; these have narrowed in ranged and shifted toward the right after the 
model corrections.  
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Figure 2.17 Estimated water, lipid, and protein thickness distributions of sampled population. The top figure shows 
distributions before and after bovine model corrections, and the bottom figure shows these for the chicken model 
corrections. 
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Discussion 
The above experiments seemed to show that mass attenuation differences 
between biological and their calibration equivalent can become problematic for 
estimating compositional estimates, particularly when estimating three compositions 
and/or at varying kVp settings. A promising correction for such estimates seems to be 
deriving a linear map between the biological and calibration materials. Indeed, the oil 
and water experiments show that energy-dependent estimates of materials seem to be 
corrected using a map between the WLP calibration materials and bovine. The transfer 
function 𝐵 was used as the linear map, and closer inspection of this function provides 
some intuition about how this correction works. For all three transformations of (𝑊 →
𝑊ᇱ, 𝐿 → 𝐿ᇱ, 𝑃 → 𝑃′), the lipid vector in the transfer function does not seem to have any 
effect when each material is linearly mapped from the calibration material space to 
bovine. When the transfer function is applied to the lipid component, the scalar value for 
the lipid vector (b22) is 1. When the transfer function is applied to the water and lipid 
components, the scalar value for the lipid vector is approximately 0 (b21 and b23). 
Concomitantly, the water and protein vectors are scaled for every mapping. These two 
effects indicate that water and protein are the components that are being incorrectly 
estimated; thus, it is difficult to decouple these two components when we are in the 
calibration material space. When we applied this correction to participant estimates, this 
is what seems to occur. Water and protein compartments are scaled while the lipid 
compartment stays approximately the same (Figure 2.17). This transformation arrives at 
composition estimates that seem to be more realistic values, removing most of the 
negative protein errors.  
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In a related study by Ding et al., they analyzed the chemical composition of lean 
and adipose bovine and chicken samples and compared it to estimates based on the 
three-compartment breast technique but for computed tomography.[40] The WLP 
content was approximately 0.80/0.02/0.17 for their lean bovine sample and 
0.11/0.85/0.02 for the bovine adipose sample, respectively. As mentioned previously, 
the volumetric fractions of W/L/P for our samples were 0.81/0.012/0.178 for the lean 
muscle and 0.13/0.855/0.015 for the suet. These findings are consistent with each 
other. In previous work, compared the pre- and post-bovine WLP estimates of cadaver 
breast to estimates from a chemical composition analysis.[51] The combined RMSE for 
WLP estimates was 29.8% for pre-bovine estimates and 15.9% for post-bovine 
estimates. For Ding et al., their combined RMSE was 2.7%. It is important to note that 
Ding et al. seem to achieve more accurate results because (1) they used two more 
biologically equivalent materials for their calibration phantom (water and vegetable oil) 
and (2) the difference in energy between their LE and HE images is much higher for CT 
than FFDM. They acquired their images at 100 kVp, 20 keV was the cutoff for their 
lowest energy, and 40 keV was selected as the splitting energy between their LE and 
HE bins. This would yield less correlation between LE and HE images since there would 
be greater separation between Compton and photoelectric events.  
The results of this study should be considered when using dual energy X-ray 
techniques that involve calibration materials at varying kVp energy levels. This would 
involve applying the 3CB technique for other imaging modalities, such as breast 
tomosynthesis. Although the bovine correction seemed to have corrected for unrealistic 
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estimates, a combined RMSE of 15.9% is still not optimal. Higher energy separation 
between the LE and HE images should help ameliorate this error.  
One limitation of this study is that the bovine correction may not cover the entire 
range of WLP variations found in breasts, and is perhaps the reason why we still see 
negative protein estimates for some lesion samples. As an example, although the 
bovine correction removed the estimate differences between the two energy levels, it 
still did not accurately estimate it for either both water and oil (and intended target of 30 
mm). We believe that this is because the bovine phantom did not contain a 100% lipid 
compartment or 100 % water compartment. It is, therefore, imperative not to over fit 
when creating a map between the two material spaces. Another limitation is that the 
bovine and chicken maps were derived using a specific X-ray machine, and differences 
between X-ray sources among machines may create large enough errors in estimates 
that a bovine calibration may be needed for each X-ray machine that is used for clinical 
studies. It is also particularly important to test whether the bovine map is stable over 
time, especially for longitudinal studies. Lastly, there may be limitations in the bovine 
and chicken maps because of inherent differences between animal and human tissues. 
Experiments comparing the chemical composition of cadaver breasts and thickness 
estimates using the bovine map show similar estimates, however.[51] 
In conclusion, energy-dependent differences between biological materials and 
their calibration equivalents may be corrected using a linear map between the two 
material spaces. This map, although itself still energy-dependent, could be used to 
correct erroneous compositional estimates for dual-energy mammography techniques. 
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Chapter 3 Studies on Other Error Sources 
 
After acquiring the LE image, HE image, and total breast thickness estimate at 
every pixel (i.e., the breast thickness map) for 3CB, the next part is estimating the 
water, lipid, and protein compartment images. A calibration phantom is used to derive 
this 3CB composition based on a linear mapping of LE, HE, and total breast thickness 
measurements. There exists, however, sources of error that can influence LE and HE 
measurements and, thus, 3CB composition estimates. Two of these error sources are 
discussed in this chapter, and a third was covered more in-depth in Chapter 2.  
Flat-Fielding 
 
Full field digital mammography (FFDM) scanners typically acquire polychromatic 
X-ray projection images using cone-beam source geometry. The intensity that is 
measured at a detector’s pixel location—even when no object is present—varies 
because of numerous factors, and nonuniformity due to cone-beam geometry becomes 
important when performing compositional measurements. Linear and non-linear 
corrections have been developed by Seibert et al. and Kwan et al.[54, 55] Here we 
develop an empirical polynomial model, similar to Kwan et al.’s, to apply flat-fielding 
(gain) corrections to X-ray projections.  
 
Methods 
Hologic Selenia full-field digital mammography system (Hologic, Inc.) was used 
to acquire all images. CIRS (Computer Imaging Reference Systems, Inc.) phantom 
slabs with 50% fibroglandular and 50% adipose breast tissue equivalent materials were 
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used for all images. Three phantoms of thickness 4, 2, and 1 cm were stacked in 
different combinations to obtain scans of 1 – 8 cm thicknesses at 1 cm intervals. The 
imaging parameters for the images are shown in Table 3.1.  
Table 3.1 Scanner settings for BR50/50 CIRS phantoms for flat-fielding model  
kVp 
Anode-
filter(s) 
Combination mAs 
25-31 Mo/Mo 100 
32 Mo/Rh 100 
39 Mo/Rh-Al 100 
 
MATLAB (Natick, Massachusetts, USA) software was used to create empirical 
flat-fielding models. First, the 2D slab images were turned into 3D surface images, 
where the x and y axes corresponded to pixel locations and the z-direction to image 
intensity. Next, a 10x10 moving window median filter was applied to the surface image 
to remove stochastic noise. The surface image 𝑆௜௡ was then normalized in two steps. 
First, the scanner’s DC component (𝐼஽஼, taken from the DICOM image header) was by 
removed and a pre-normalization was applied with the initial intensity derived from the 
𝐼଴ model (see Empirical 𝐼଴ Model found later in this chapter) using the following equation 
𝑆ே଴ ൌ ሺ𝑆௜௡ െ 𝐼஽஼ሻ/ሺ𝐼଴ െ 𝐼஽஼ሻ Equation 3‐1 
Secondly, this was normalized by the intensity value of 𝑆ே଴ located at ሺ𝑥଴, 𝑦଴ሻ, which is a 
small region of interest surrounding the point where the incident X-ray beam is 
perpendicular to the detector plane. This made it so that the flat-fielding model would be 
independent of exposure (mAs) settings, so  
𝑆ே ൌ 𝑆ே଴/𝑆ே଴ሺ𝑥଴, 𝑦଴ሻ Equation 3‐2 
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After normalization, 𝑆ே was downscaled by a factor 𝑐 ൎ 0.15 such that the smallest 
positional dimension (either x or y dimension) of the image (in this case, the x-axis) was 
size 250, so  
𝑆ௌ ൌ 𝑆ேሺ𝑐 ∗ 𝑥௦௜௭௘, 𝑐 ∗ 𝑦௦௜௭௘ሻ Equation 3‐3 
Following this, a third-degree polynomial in x and y was made using the MATLAB 
function fit. Polynomial fits were made for all thicknesses (𝑇) and kVps, so the flat-
fielding model function is the function 𝑆ிிெሺ𝑥, 𝑦, 𝑘𝑉𝑝, 𝑇ሻ. After the flat-fielding correction 
is applied to 𝑆ௌ, we get 𝑆ிி ൌ ௌೄௌಷಷಾ. To validate fitting, the normalized RMSE 𝑅𝑀𝑆𝐸ே ൌ
100 ∗ ோெௌாఙ೘೐ೌ೙  ሺ%ሻ between the surface fit and 𝑆ௌ was compared to the normalized 
standard deviation 𝜎ௌ஽ே of the median-filtered image noise, where  
𝜎ௌ஽ே ൌ 100 ∗ 𝜎ௌ஽𝜎௠௘௔௡ ሺ%ሻ 
Equation 3‐4 
𝜎ௌ஽: 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑆ௌሺ𝑥଴,𝑦଴ሻ  
𝜎௠௘௔௡: 𝑚𝑒𝑎𝑛 𝑜𝑓 𝑆ௌሺ𝑥଴, 𝑦଴ሻ  
Note that 𝜎ௌ஽ே is smaller than the actual image noise since it is the residue noise left 
over after a median filter was applied to the original image. 
Results 
Figure 3.1, Figure 3.2, Figure 3.3 depict how well a polynomial surface fit the 
input for the three different filter conditions of the slab images. In each figure, the 1 cm 
(top) and 8 cm (bottom) cases are shown. For each thickness case, the top-left surface 
plot is the median-filtered, normalized, and downscaled input image 𝑆ௌ, which varied up 
to approximately 15% in normalized intensity. The top-right surface plot is the third-
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degree polynomial fit in 𝑥 and 𝑦 of 𝑆ௌ. The bottom plot is 𝑆ிி, the resulting surface plot 
after the flat-fielding correction is applied to 𝑆ௌ. In almost all surface fit cases, the 
polynomial surface fit performed better than the normalized median-filtered image noise 
of the input image (i.e., 𝑅𝑀𝑆𝐸ே ൏ 𝜎ௌ஽ே for almost all cases). Figure 3.4 shows plots of 
𝑅𝑀𝑆𝐸ே and 𝜎ௌ஽ே as a function of kVp. These were used to verify a good fit for the 
polynomial model. Plots similar to this were made for all thicknesses. Only the surface 
plots for ሺ𝑇 ൌ 6 𝑐𝑚, 𝑘𝑉𝑝 ൌ 31ሻ and ሺ𝑇 ൌ 4 𝑐𝑚, 𝑘𝑉𝑝 ൌ 26ሻ had 𝑅𝑀𝑆𝐸ே ൐ 𝜎ௌ஽ே, but these 
were within rounding error.  
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Figure 3.1 Flat-fielding surface fits for kVp = 29 (Mo/Mo anode/filter combinations), 1 cm (top plots) and 8 cm (bottom 
plots). For 1 cm plots, 𝝈𝑺𝑫𝑵 ൌ 𝟎. 𝟓𝟗 %, 𝑹𝑴𝑺𝑬𝑵 ൌ 𝟎. 𝟑𝟔%. For 8 cm plots, 𝝈𝑺𝑫𝑵 ൌ 𝟎. 𝟖𝟑 %, 𝑹𝑴𝑺𝑬𝑵 ൌ 𝟎. 𝟔𝟖%. 
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Figure 3.2 Flat-fielding surface fits for kVp = 32 (Mo/Rh anode/filter combinations), 1 cm (top plots) and 8 cm (bottom 
plots). For 1 cm plots, 𝝈𝑺𝑫𝑵 ൌ 𝟎. 𝟕𝟗 %, 𝑹𝑴𝑺𝑬𝑵 ൌ 𝟎. 𝟒𝟑%. For 8 cm plots, 𝝈𝑺𝑫𝑵 ൌ 𝟏. 𝟎𝟔%, 𝑹𝑴𝑺𝑬𝑵 ൌ 𝟎. 𝟕𝟔%. 
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Figure 3.3 Flat-fielding surface fits for kVp = 39 (Mo/Rh-Al anode/filters combinations), 1 cm (top plots) and 8 cm 
(bottom plots). For 1 cm plots, 𝝈𝑺𝑫𝑵 ൌ 𝟏. 𝟓𝟑%, 𝑹𝑴𝑺𝑬𝑵 ൌ 𝟎. 𝟒𝟒%. For 8 cm plots, 𝝈𝑺𝑫𝑵 ൌ 𝟐. 𝟐𝟐%, 𝑹𝑴𝑺𝑬𝑵 ൌ 𝟏. 𝟑𝟐%. 
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Figure 3.4 Flat‐fielding plots of 𝝈𝑺𝑫𝑵 and 𝑹𝑴𝑺𝑬𝑵 for 1 cm (top) and 8 cm (bottom) surface fits as a function of kVp.  
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Figure 3.5 shows the coefficients of a typical fit model created for 𝑘𝑉𝑝 ൌ 29. The 
𝑥 axis for each plot is the thickness 𝑇 in 𝑐𝑚, and the 𝑦 axis is the intensity value of a 
coefficient 𝑝௜,௝, 𝑤ℎ𝑒𝑟𝑒 𝑖 ൌ 0, … , 3 𝑎𝑛𝑑 𝑗 ൌ 0, … , 3. Using the values for measured 
thicknesses 1, 2, …, 8 cm, linear interpolation was used to estimate coefficient values 
for all thicknesses in the range ሾ1, 8ሿ 𝑐𝑚. This makes it so that the flat-fielding model 
function 𝑆ிிெሺ𝑥, 𝑦, 𝑘𝑉𝑝, 𝑇ሻ is continuous in the range 𝑇 ൌ ሾ1, 8ሿ 𝑐𝑚.  
 
Figure 3.5 Flat‐fielding model coefficients for 29 kVp. Linear interpolation was used to create flat‐fielding values for all 
thicknesses between 1 and 8 cm, so the “Fit Curve” directly overlays over the plot of the surface fit coefficient values.  
 
Discussion 
The goal of the above was to create a method to correct for flat-fielding errors 
found when acquiring X-ray projection images. This correction is important for 
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estimating 3CB water, lipid, and protein compositions, since the method uses a 
calibration phantom to perform a linear mapping of LE and HE measurements. From the 
experiments, it was shown that there can be nonuniformity of up to a 15% due to the 
geometry of cone-beam X-ray projections used in mammography. To minimize this error 
and get an accurate linear mapping between the calibration phantom and breast 
measurements, LE and HE values should be position-independent. A third-degree 
polynomial flat-fielding model 𝑆ிிெሺ𝑥, 𝑦, 𝑘𝑉𝑝, 𝑇ሻ seemed to correct geometric-based 
errors. The resulting flat-fielded image 𝑆ிி had non-uniformity errors reduced to 
approximately 2%. This method can be applied to LE and HE phantom and breast 
images before the 3CB composition is estimated. A thickness map would be needed to 
apply this flat-fielding correction to projection images. In addition, flat-fielding models 
would have to be made for each scanner that is used to acquire 3CB images by 
scanning uniform thickness breast composition phantoms, since these empirical models 
can vary between scanners. 
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Initial Intensity (𝐼଴) Correction 
 
In 3CB imaging, WLP thicknesses are estimated by using LE and HE log-signal 
functions 𝐴௜:  
𝐴௜ ൌ ln ቀ ூூబቁ, 
Equation 3‐5 
where 𝐼 is the measured attenuation photon intensity, 𝐼଴ is the nonattenuated photon 
intensity, and 𝑖 is either 𝐿𝐸 or 𝐻𝐸. It is, therefore, important to accurately estimate 𝐼଴ for 
both calibration phantom and breast images. Here we discuss the two methods that 
were used for estimating 𝐼଴ in 3CB images. This first method is based on an empirical 
model made from measuring nonattenuated images at varying exposures. The second 
one estimates 𝐼଴ from the single X-ray absorptiometry (SXA) step phantom that is used 
when acquiring 3CB images.  
Methods 
 
Empirical 𝐼଴ Model 
 
An empirical 𝐼଴ model was created from nonattenuated X-ray images scanned 
with a Hologic Selenia FFDM system. Scans were taken at 20, 50, and 100 mAs and 
25-32 and 39 kVp. A small ROI (75x150 pixels) was sampled from each image at the 
same location—where the X-ray source was perpendicular to the detector plane. A 
linear model, which uses mAs and kVp as dependent variables, was created using the 
20 and 50 mAs samples, since the detector saturated at 100 mAs for higher kVps. To 
validate the empirical 𝐼଴ model, a two-compartment model was tested first. The 51-point 
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calibration point was sampled at ROIs that contained only water and protein, which shall 
be known as the two-compartment calibration phantom (2CCP). A two-compartment 
intermediate phantom (2CIP) was made by adding 1 cm of water to the 2CCP. The 
2CCP was used for calibrating linear mapping equations, while the 2CIP was used to 
test accuracy. The percent 𝑅𝑀𝑆𝐸, 𝑅𝑀𝑆𝐸௉ ൌ 100 ∗ ோெௌா୫ୟ୶ሺ஺௖௧௨௔௟ሻ, was used for this accuracy 
test.  
 
𝐼଴ from SXA Phantom 
 
The SXA phantom, which is a step phantom that is normally used to estimated 
breast thickness at every pixel, was used to derive the negative log-signal values (െ𝐴௜ ) 
of a uniform material as a function of thickness.[53] This phantom was already included 
in 3CB FFDM images, since it is part of the routine procedure. A flat-fielding correction 
(see Flat-Fielding section from earlier in this chapter) was applied to the SXA phantom 
based on its known region-of-interest thicknesses. The ROIs of the SXA phantom were 
then located in the image by isolating the SXA phantom lead beads and then mapping 
ROI coordinates from these lead bead locations. Next MATLAB software function polyfit 
was used to create a first-degree polynomial fit. A first-degree polynomial was chosen 
since െ𝐴௜ is a linear function of material thickness 𝑇. Lastly, 𝐼଴ was estimated using this 
fitting function for 𝑇 ൌ 0 𝑚𝑚.  
Results 
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Figure 3.6 The ROI sample location for the empirical 𝑰𝟎 model 
Table 3.2 lists the compositions of the two-compartment phantoms. Figure 3.7 
shows R (LE/HE) vs. HE attenuation values for the 2CCP and 2CIP phantoms before 
the empirical 𝐼଴ model was applied. Curves were fit to the varying compositions of the 
2CCP. Some of these compositional curves converge, which implies that the 2CCP 
linear mapping will poorly predict compositional estimates.  
Table 3.2 Compositions of the two-compartment phantoms for testing the empirical 𝑰𝟎 model 
ROI No. 
2CCP 
Water 
Thickness 
(cm) 
2CCP 
Protein 
Thickness 
(cm) 
2CIP Water 
Thickness 
(cm) 
2CIP 
Protein 
Thickness 
(cm) 
1 6 0.89 7 0.89 
2 6 1.34 7 1.34 
3 4 0.59 5 0.59 
4 4 0.89 5 0.89 
5 2 0.3 3 0.3 
6 2 0.44 3 0.44 
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7 6 0 7 0 
8 6 0.44 7 0.44 
9 4 0 5 0 
10 4 0.3 5 0.3 
11 2 0 3 0 
12 2 0.15 3 0.15 
 
.  
 
Figure 3.7 R vs. HE Plots of two-compartment phantoms before the empirical 𝑰𝟎 model was applied. 
Figure 3.8 shows the R vs. LE plots of the two-compartment phantoms after the 
empirical 𝐼଴ model was applied. In this plot, only two of the 2CCP curves converge. After 
investigation, however, the composition of 2CCP point 12 had the incorrect composition 
(8.96 %); it is also the ROI most susceptible to error, since it is the region with the 
thinnest amount of protein content. The 𝑅𝑀𝑆𝐸௉ for the 2CCP using the linear mapping 
55 
 
created from the 2CCP itself was 1.39% for water and 6.39% for protein. For validation, 
the 𝑅𝑀𝑆𝐸௉ for the 2CIP was 5.37% for water and 25.55% for protein.  
 
Figure 3.8 R vs. HE Plots of two-compartment phantoms before the empirical 𝑰𝟎 model was applied. 
 
Figure 3.9 shows the nine ROIs of the SXA phantom that were used to estimate 
the SXA phantom-derived 𝐼଴. The lead beads can be seen, and their estimated locations 
are shown by a red crosshair. A sample fit for 𝐼଴ derived from the SXA phantom for a 
breast scanned at 28 kVp is shown in Figure 3.10 and Figure 3.11. The 𝐼଴ for the LE CP 
and breast images was 6892.68 and 3701.56, respectively; the 𝐼଴ for the HE CP and 
breast images was 2597.44 and 1641.72, respectively.  
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Figure 3.9 Located SXA ROIs phantom for estimating 𝑰𝟎 from the SXA phantom log-signal values.  
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Figure 3.10 LE calibration phantom and breast 𝑰𝟎 derived from SXA phantom 
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Figure 3.11 HE calibration phantom and breast 𝑰𝟎 derived from SXA phantom 
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Discussion 
The goal of the above was to create and test methods for estimating 
nonattenuated photon intensity, 𝐼଴. The experiments for the empirical 𝐼଴ model seemed 
to produce better R v. LE curves for linear mapping estimates. Still, validation with the 
2CIP had over 20% 𝑅𝑀𝑆𝐸௉ for the protein estimates. This could probably be attributed 
to the linear mapping performing poorly for estimates outside of its calibrated 
thicknesses, since the total thickness for some of the predictions were 7 cm. When 
deriving 𝐼଴ from the SXA phantom, some of the attenuations at higher thicknesses were 
not aligned with the rest of the data. This is most likely because the ROIs for these 
sampled outside the thickness region. It is, therefore, important to ensure that mapped 
ROIs are accurate for future fittings, though these did not seem to affect the actual fit 
since most of the lower thicknesses followed a linear trend. It is recommended to use 
the 𝐼଴ derived from the SXA phantom to estimate 𝐼଴, since it is a measured prediction 
from the same image as being predicted. If the SXA phantom is not available, however, 
a robust empirical 𝐼଴ model using more sample points at varying mAs and taken at 
different days should be made for every scanner. Even then, a mechanism to calibrate 
and validate the empirical model would most likely be necessary due to quantum 
fluctuations in X-ray scanners. 
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Chapter 4 3CB Tomosynthesis  
 
Introduction 
 
Tomosynthesis is an X-ray imaging modality that is similar to computed 
tomography (CT). Fundamental work for tomosynthesis was done in the 1930s, but 
tomosynthesis did not become clinically relevant until the late 1990s, “when flat-panel 
radiographic detectors were introduced.”[56] One of the main differences between CT 
and tomosynthesis is the sweep angle; CT sweeps at 180° to fully reconstruct a 3D 
volume from 2D projections, whereas tomosynthesis sweeps anywhere in the 15° – 50° 
range to reconstruct a pseudo-3D volume. This pseudo-3D volume creates focal plane 
“slices” of the imaged object. Since only a limited angle range is scanned, 
tomosynthesis has anisotropic spatial resolution. The in-plane (x-y direction) spatial 
resolution can outperform CT, but the z-direction spatial resolution can vary between 1 
mm (full-width half maximum of the point spread function) for a 30° sweep angle 
tomosynthesis scanner and 4 mm for 10° sweep angle scanners.[57] Over the past two 
of decades, research efforts have focused on making tomosynthesis clinically 
applicable, and there have been numerous studies on evaluating its applicability to 
breast cancer detection and diagnosis. 
One of the largest retrospective reading studies of 7060 patients that compared 
digital breast tomosynthesis (DBT) to FFDM found that the sensitivity of DBT was 89% 
and 87% for FFDM, which showed “borderline significant improvement (p = 0.07).”[58, 
59] As noted by Gilbert et al. in their review, several other studies show similar or 
improved sensitivity over FFDM. As for specificity, most studies included in Gilbert et 
61 
 
al.’s review showed a significant increase: 74% for DBT and 51% for FFDM in one 
study.[60] 
As DBT becomes more clinically prevalent, the 3CB technique should also be 
able to function with DBT. This chapter covers early investigations into making 3CB 
applicable for DBT. First, DBT imaging parameters—including filter type and 
thickness—for 3CB HE images are investigated. The second part of this chapter 
investigates potential methods for determining breast thickness, which is an essential 
part of the 3CB technique, from DBT projections. 
 
Part I: Optimizing filter and imaging parameters for high-energy projections 
 
The goal of this experiment was to find the optimal filter and imaging parameters 
to use for acquiring HE DBT projections. For commercial tomosynthesis scanners, such 
as GE SenoClaire, the peak energy available for scanning is higher than FFDM (49 kVp 
vs. 39 kVp). This allows for more energy separation between the LE and HE images, 
creating greater orthogonality/uncorrelation between measurements and, thus, 
solutions. Using higher peak energies, however, can also increase patient dose. One 
3CB constraint is that the dose of the HE image should be approximately 10% of a 
regular diagnostic exam dose (i.e., 3CB LE image dose) while optimizing image 
contrast-to-noise ratio (CNR). Here we investigate this and recommend a filter for 
acquiring HE DBT projections.  
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Methods 
All images for the measurements below were acquired using GE Healthcare 
(Chicago, IL) SenoClaire DBT. This scanner acquires nine projections over a 25° sweep 
angle. At first, both aluminum and copper filters were considered. After cursory 
simulations, however, it was determined that an aluminum filter would have to be 
approximately 12 cm thick, which is clinically impractical. Copper filters were considered 
as the choice material since they attenuate X-ray intensity at a higher rate than 
aluminum, are readily available, and are cost effective.  
Average Glandular Dose  
The average glandular dose (AGD) is defined as 𝐷௚ ൌ 𝐷௚ே ∗ 𝑘 where 𝑘 (mGy) is 
the incident air kerma at the entrance surface of the breast and 𝐷௚ே (mGy/mGy) is the 
normalized glandular dose coefficient.[61] Tables of 𝐷௚ே values were computed by GE 
Healthcare for Rhodium-Rhodium anode-filter combinations, 49 kVp, 2-9 cm breast 
thicknesses, and 0, 50, and 10 % breast glandularity. Extrapolations were computed 
from these tables to obtain values for all relevant copper thicknesses. Along with AGD, 
corresponding half value layer (HVL) values for Cu filter thicknesses were also 
measured. In our experiments, 𝐻𝑉𝐿 ൌ ୪୬ ଶఓ  was computed by measuring the air kerma of 
aluminum, plotting this value as a function of aluminum thickness, and obtaining the 
attenuation coefficient 𝜇 by fitting an exponential function to corresponding plots. All air 
kerma values were measured using Radical Corporation (Monrovia, CA, USA) model 
1515 ion chamber. Two measurements were performed for estimating the AGD of 3CB 
HE images. The goal for the first measurements was to determine optimal mAs for a 4 
cm breast with 50% glandularity. The goal for the second measurements was to 
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compute the dose for additional breast thicknesses using the optimal mAs obtained 
from the first measurement. 
CNR 
A GEN3 phantom—which is a step phantom made of Plastic Water® and 
machinable wax to mimic the water and lipid compartments—was used to acquire CNR 
measurements. Ideally, these represent the two bounds for contrast found in 3CB 
images, so the aim was to maximize this contrast. A BR3D phantom, which mimics 
adipose and fibroglandular tissues, was used to obtain imaging settings (kVp, mAs, and 
target-filter combinations) for the GEN3 phantom images. Tomographic images of the 
BR3D phantom were first acquired, and then single 2D projections of the GEN3 
phantom were taken using these imaging parameters. The mAs parameter was reduced 
9-fold for the 2D projections since each DBT sweep acquires nine projections. CNR was 
estimated by sampling the 2, 4, and 6 cm regions of the GEN3 phantom that contained 
either pure Plastic Water® or machinable wax (see Figure 4.1). The background of the 
GEN3 images were sampled for noise estimates (i.e., denominator) using the equation 
𝐶𝑁𝑅 ൌ ሺ𝑅௅ െ 𝑅ௐሻ𝜎஻௄ீ  
where 𝑅௅ is the lipid compartment (machinable wax) intensity ratio of the LE and HE 
GEN3 phantom images, 𝑅ௐ is the water compartment (Plastic Water®) intensity ratio of 
the LE and HE GEN3 phantom images, and 𝜎஻௄ீ is the standard deviation of the noise 
in the image. The intensity ratio between LE and HE images was used since 3CB 
images are computed using both LE and HE images. Normalized CNR was also 
computed using the equation 
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𝐶𝑁𝑅𝑁 ൌ 𝐶𝑁𝑅√ሺ𝐴𝐺𝐷ሻ 
 
 
Figure 4.1 A projection of the GEN3 phantom showing sampled regions of interest.  
 
Results 
Figure 4.2 and Figure 4.3 show the AGD estimates and HVL plots for the first set 
of AGD measurements. For the AGD estimates, the lowest available mAs for tomo (36 
mAs total) was used. An additional mAs (71 mAs) was also measured for Cu thickness 
= 0.4064 mm. For the HVL estimates, all exponential fits had 𝑅ଶ ൐ 0.99, indicating little 
error in air karma measurements. Unfortunately, time constraints (a limited window was 
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given to perform air kerma measurements during patient hours) did not allow HVL 
estimates for all copper filter thicknesses. The 71 mAs setting was chosen as optimal 
since it optimizes for CNR and falls within the 10% of LE AGD constraint. 
 
Figure 4.2 LE and HE AGD estimates for a 4 cm thick, 50 % glandularity breast for the first set of AGD 
measurements. 
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Figure 4.3 HVL estimation plots (air kerma vs. aluminum thickness) for first set of AGD measurements.  
 
Figure 4.4 and Figure 4.5 show the results for the second set of AGD 
measurements. For the AGD estimates, all power fit curves had 𝑅ଶ ൐ 0.99. Copper filter 
thickness selection seems to be constrained by the 6 cm dose value since optimizing for 
one based on the 10% of LE AGD target dose from this measurement would satisfy the 
LE AGD target for smaller breast thicknesses. For the HVL estimates, all exponential fit 
curves had 𝑅ଶ ൐ 0.98.  
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Figure 4.4 LE and HE AGD estimates for 2, 4, and 6 cm thick, 50 % glandularity breasts for the second set of AGD 
measurements. 
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Figure 4.5 HVL estimation plots (air kerma vs. aluminum thickness) for second set of AGD measurements 
Table 4.1 shows the imaging parameters for the acquired CNR images.  
Table 4.1 Imaging Parameters for CNR Images 
Breast 
Thickness kVp 
Cu 
Thickness  
(mm)  mAs   Anode Filter 
2  26  0  5.1 Mo  Mo 
4  29  0  5.9 Rh  Rh 
6  31  0  9.5 Rh  Rh 
2/4/6*  49  0  8 Rh  Rh 
49  0.127  8 Rh  Rh 
49  0.254  8 Rh  Rh 
y = 0.2627e‐0.145x
R² = 0.9996
y = 0.5447e‐0.177x
R² = 0.9994
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49  0.381  8 Rh  Rh 
*kVp is set to 49 for the HE images, so breast thickness does not affect HE 
kVp 
 
Figure 4.6 shows plots of the CNR and CNRN estimates for 2, 4, and 6 cm breast 
thicknesses. In all thicknesses, CNR and CNRN estimates are within 15% of each other 
for all measured values (0.127, 0.254, and 0.381 mm). The fourth point shown (Cu 
thickness = 0.4064 mm) in the CNRN plots is an extrapolated value from the fit equation 
derived from the plotted measurements.  
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 Figure 4.6 The CNR and Normalized CNR for varying breast thicknesses.  
Discussion 
In the above experiments, the main goal was to optimize imaging parameters 
and a filter for HE 3CB images. A Cu filter of 0.4064 mm (16 mils) seems to be optimal 
in terms of meeting dose requirements, availability, and CNR. Imaging at 71 mAs 
optimizes CNR while satisfying dose requirements. One limitation of this study is that 
breast thicknesses higher than 6 cm, which can be found in clinical practice, were not 
considered. It would be valuable to see if dose requirements are met using a 0.4064 
mm filter at 71 mAs exposure time for thicker breasts. Lastly, it is extremely important to 
note that when acquiring HE 3CB images, technicians must ensure that the Cu filter is 
installed. If the Cu is not installed, the given dose to patients would be approximately 10 
times the LE image dose. 
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Part II: Methodology for determining 3D breast thickness from raw 
tomosynthesis projections 
 
One important aspect of the 3CB technique is breast thickness estimation. For 
FFDM 3CB, an SXA phantom is used to estimate breast thickness using known 
geometric positioning of the phantom and then determining the paddle tilt angle and 
.[Check Supplement submission to see what I wrote in there about this]. Since DBT 
acquires multiple projections during its sweep, however, it may be possible to estimate 
breast thickness from these raw projections. The main goal of the following experiments 
was to identify possible variables for accurately estimating breast thickness from DBT 
raw projections.  
 
Methods 
 
The ASTRA Toolbox (Vision Lab, University of Antwerp, Belgium and Centrum 
Wiskunde & Informatica (CWI) in Amsterdam, The Netherlands) was used to create 
simulations in MATLAB (Natick, Massachusetts, USA) software. It is “a software 
platform to address the need for a flexible, efficient, and easy to use development 
platform for tomographic algorithms.”[62, 63] The geometry for the simulations was 
meant to replicate a typical DBT imaging modality and is shown in Figure 4.7. 
Sinograms were created from the simulated tomosynthesis projections of a breast-like 
object. Examples of sinograms for CT and DBT scans are shown in Figure 4.8.  
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Figure 4.7 ASTRA toolbox experiment imaging geometry and parameters.  
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Figure 4.8 Example sinograms of a simple breast phantom for CT and DBT simulations. (a), (b), and (c) show the 
top, side, and front views of the geometry of the object. (d) shows a sinogram made from a simulated CT scan with 
59 projections over a sweep angle 𝜽 ൌ 𝟏𝟖𝟎° (𝒅𝜽 ൌ 𝟑. 𝟏𝟐𝟓°). (e) shows a sinogram made from a simulated DBT scan 
with 9 projections over a sweep angle 𝜽 ൌ 𝟐𝟓° (𝒅𝜽 ൌ 𝟑. 𝟏𝟐𝟓°).  
 
Sinograms were selected for investigation because they contain z-direction (the axis 
perpendicular to the detector plane) geometric information about an imaged object. It 
was hypothesized that by varying breast thickness, intensity (i.e., breast density), and 
diameter of simulated DBT projections, sinograms would contain information that 
correlated with breast thickness. Initial investigations sought to see if these parameters 
could be minimized with an error function. Next, ten random breast sinograms were 
generated by varying breast thickness, intensity, and diameter from simulations to see if 
it was possible to solve for these parameters. An iterative method solved for these by 
minimizing RMSE between a randomly generated sinogram and a library of generated 
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sinograms. To aid in finding the global minimum instead of an erroneous local minimum, 
only sinograms with breast parameters that were within 2 mm, 5mm, and 10 of the 
breast thickness, diameter, and intensity were searched. In real-world applications, 
these initial parameters would be the breast thickness information from the DICOM 
image header (e.g., the variable BodyPartThickness), the breast diameter derived by 
measuring breast thickness from the perpendicular tomo projection (𝜃 ൌ 0°), and breast 
intensity from the average intensity of the breast. 
Results 
Figure 4.9 shows the cross-sectional view and sinogram of simple a breast object 
of varying thickness that was generated using the ASTRA Toolbox. The parameters for 
the top figures are 20 mm, 100 mm, and 200 for breast thickness, diameter, and 
intensity, respectively. The bottom figure varied only in breast thickness (60 mm). Note 
the difference in the edges between the two sinograms. The 60 mm breast thickness 
sinogram seems to have a smaller difference between the starting (left) edge value of 
the first projection (x-axis value = 68) and the ninth (x-axis value = 59). This difference 
approximately doubles for the 20 mm breast (x-axis value = 68 for the first projection 
and x-axis value = 49 for the ninth).  
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Figure 4.9 Cross-sectional view and sinogram of simple a breast object of varying thickness (top thickness = 20 mm, 
bottom thickness = 60 mm). 
Figure 4.10 summarizes the feasibility of a using an error function to minimize the 
simulated breast parameters. For each plot, one parameter varied while the other two 
were held constant. Minima are found for the three parameters for a simulated breast 
sinogram. After these initial findings, the RMSE was computed between a sinogram of 
randomly generated breast parameters and a library of sinograms. The iterative method 
varied all three parameters in each iteration and is shown in Figure 4.11. The estimated 
minima are found for each iteration (top, middle, and bottom plots). The target values for 
breast thickness, diameter, and intensity were 53 mm, 77 mm, and 200, respectively. 
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Figure 4.10 RMSE of a pre-selected breast sinogram and generated sinograms of varying breast parameters.  
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Figure 4.11 The RMSE between a sinogram of random breast parameters and a library of sinograms for an iterative 
method.  
  
Figure 4.12 top plot shows the parameters for the ten breast sinograms that were 
generated, and the bottom plot shows the error between actual and iteratively-found 
estimates. In all cases, the iterative method had the most error in the intensity 
parameter. Estimated breast thicknesses and diameters were within their search range, 
±2 mm and ± 5mm, respectively.  
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Figure 4.12 (Top) Breast sinograms of randomly generated thickness, diameter, and intensity parameters and 
(Bottom) the error between actual and iteratively-found estimates.  
 
 
Discussion 
 
The above investigations sought to derive potential variables of interest as 
predictors of breast thickness from raw DBT projections using the ASTRA Toolbox. 
Thickness estimates derived through an iterative search method seem promising, 
though the search method found it difficult to accurately estimate the breast intensity 
parameter. Since intensity had a larger search range (±10), it is probably more likely to 
find a local minimum instead of the global one. From Figure 4.9, however, sinogram 
edges could potentially be used as a predictors of breast thickness estimates from raw 
DBT projections. 
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Chapter 5 Accurate body composition estimates from whole-body 
silhouettes 
 
Dual-energy X-ray Absorptiometry (DXA) has been widely used to study body 
composition, and obesity has been linked as a major risk factor for cancer.[64] More 
specifically, large epidemiological studies have “…found that overweight or obese 
women are at increased risk of developing postmenopausal breast cancer.”[65] In 
addition, current trends show that endocrine-based mechanisms may act as mediators 
in the link between obesity and breast cancer for postmenopausal women.[66-68] 
Moreover, monitoring and maintaining a lean body may offer “…a way in which 
[postmenopausal-]women can modestly to significantly reduce their relative breast 
cancer risk.”[66] Although unrelated to three-compartment breast imaging, here a 
method is described that could potentially help monitor lean mass from 2D optical 
images, which was developed by Avila et al during his graduate studies.[69] 
Introduction 
 
With the globalization of high-caloric foods, the rate of obesity in children of 
developing regions such as Southeast Asia and China has increased from 2 to 10% 
over the last 20 years.[70] In many developing countries, there is a dual burden of 
malnutrition, where under- and over-nutrition occur simultaneously.[71] Body mass 
index (BMI) is often used as a measure of under- and over-nutrition since it describes 
the body weight relative to height and it can be measured with little or no cost. Studies 
have shown that increased BMI is associated with increased risk for diabetes[72] and 
metabolic syndrome;[73] however, because BMI is only a measure of overall insufficient 
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or excess weight, it does not discern the relative amounts of fat and lean mass .[74-76] 
For example, there can be a two-fold variation in fat mass for a given BMI in 
children.[77, 78] Furthermore, the distribution of fat changes in children and adolescents 
throughout their development, and BMI cannot directly monitor these changes.[78] The 
relationship of BMI to percent body fat changes as a function of age and sex.[79] Must 
and Anderson have suggested using BMI Z-scores (BMIZ) instead of BMI to represent 
what is normal for BMI as a function of age and sex trends[80], and BMIZ is commonly 
reported instead of BMI in pediatric studies.  
Unlike BMI and BMIZ, the fat mass index (FMI, kg/m2) and fat-free mass index 
(FFMI, kg/m2) describe body mass in terms of fat and lean masses independently. FMI 
is a significant determinant of diabetes type and overcomes the limitation of BMI and 
BMIZ not directly measuring fat and lean masses.[81] FFMI is associated with strength 
and muscle mass and is used in sarcopenia prediction models.[82] 
To measure FMI and FFMI, total body mass must be subdivided into fat and fat-
free masses. Previous approaches to measuring FMI and FFMI include bioelectrical 
impedance analysis (BIA),[83, 84] underwater weighing,[85] air-displacement 
plethysmography,[86] deuterium dilution,[87, 88] and dual-energy X-ray absorptiometry 
(DXA).[89-91] Of these, DXA is considered a reference method because few 
assumptions are made in its determination of fat and lean mass. DXA is not widely used 
to characterize body composition in large populations or in a clinical setting because the 
technique is typically more costly than other body composition methods and it uses 
ionizing radiation.[85] However, all of the techniques listed require measurement 
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devices that range from thousands to tens of thousands of dollars, making FMI and 
FFMI impractical in low-resource environments.  
An alternative approach is to quantify fat and lean masses using 
anthropomorphic body shape measures of either skinfold thicknesses or body 
circumferences. Body shape measures including waist, hip, and thigh circumferences, 
as well as sagittal abdominal diameter, are already used in epidemiological studies for 
their high association with diabetes[92] and metabolic syndrome.[93-96] In adult models 
of metabolic syndrome, BMI loses its predictive power when waist circumference is 
added to the model.[97] Skinfold thicknesses provide an estimate of subcutaneous fat 
thickness by measuring the thickness of pinched (doubled over) skin, but models of 
whole body percent body fat derived from skin fold thickness are not accurate compared 
to more direct methods like DXA.[98]  
In this study, we propose that the silhouette of a person is a reasonable 
representation of overall body shape, and that shape can be used to estimate fat and 
lean body masses. Silhouettes, or shadow images that represent the outline of objects, 
have the advantage of being easily created with minimal processing using low-
resolution cameras, which are now ubiquitous. For a proof-of-concept, we created 
silhouettes from an existing DXA whole-body dataset of a large cohort of children. This 
approach allows for testing the silhouette imaging concept and it accuracy to DXA 
before recruiting a large population of children to have new DXA and optical scans. 
Here we present a method to derive fat and fat-free indices from silhouettes and show 
their agreement with the true indices acquired using whole-body DXA scans.  
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Methods 
This study is an in-vivo, cross-sectional, comparative study using a convenience 
sample; the sample population of children varies in age, BMIZ, and sex. 
Participants 
 The participants were recruited as part of the Bone Mineral Density in Children 
Study (BMDCS). BMDCS was a prospective cohort study of 1554 children of mixed 
ethnicity ranging in age from 5 to 16 years. Begun in 2002 and sponsored by the 
National Institute for Children’s Health and Diseases (NICHD), BMDCS was designed to 
study the bone health of healthy children as they aged over a 6-year period. The scans 
used in the present study were the baseline scans from 5 different locations in the 
United States from July 2002 to November 2003.[89] The selection criteria for the 
children were defined by the BMDCS through telephone questionnaires and physical 
examination. A complete description of recruitment and the study has been 
published.[89] Two hundred children (100 male) were selected to represent a wide 
range of body shapes and demographic descriptors. Weights were measured on digital 
scales, and heights were measured using stadiometers. All measures including DXA 
were acquired while the participants were dressed in examination gowns without shoes. 
BMIZ for each participant was calculated using growth charts from the Centers for 
Disease Control and Prevention.[99] Our selection criteria was to choose the extremes 
(low and high values) for age, height and weight from both sexes, then use a random 
selection criteria for the remaining individuals. 
DXA acquisition 
Our selected children were scanned on one of four Hologic Discovery/A systems 
(Hologic, Inc., Bedford, MA). A fifth BMDCS study site was not used in our pilot because 
the children were scanned on a Hologic Discovery/W. The DXA scans created using the 
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Discovery/W have a slightly different projection of the body due to differences in the fan-
beam geometry compared to the Discovery/A. All scans were centrally analyzed at the 
University of California, San Francisco using Hologic Apex 3.0 software. FMI and FFMI 
were derived from the total body fat and lean masses as follows: FMI = fat mass/height2 
and FFMI = (lean soft tissue mass + BMC)/height2. Note that BMI = FMI + FFMI using 
this definition. Participants were centered on the scanner table with their arms out to the 
side and feet pointed downwards, which followed the manufacturer’s standard scan and 
positioning protocols.[100] Further details of the acquisition and analysis procedures are 
described elsewhere.[89]  
 
   
Figure 5.1. (left) Image of the high-energy attenuation portion of the DXA 
scan. Bone and the density of soft tissue can clearly be distinguished as 
shades of grey. (right) Silhouette representation of the same DXA image. 
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Silhouette images 
In-house algorithms written in MATLAB (MathWorks Inc.) were used to extract 
high-energy X-ray attenuation images from raw DXA image files.[101] All pixels above a 
threshold value defined the silhouette and set to “1”. All pixels with values below the 
threshold were set to “0” (see Figure 5.1). Linear spatial transformations (translation and 
rotation) were then used to align all images to each other. Images were then cropped 
above the head to remove unused pixels and at the ankles to remove the variance of 
the position of the feet. Due to the standardized geometry of DXA device, pixel 
dimensions were identical across all patients. Quality control was performed on the 
silhouettes by manually reviewing each and checking for abnormalities in the body 
positioning that was markedly different from the standard DXA positioning. 
Active Shape Modeling 
 
 
Figure 5.2. Delineation of 50 
points of interest on 
silhouettes for active shape 
modeling.   
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We built a 50-point Active Shape Model (ASM) to describe body shape.[102] See 
Figure 5.2. The selection criteria for the 50 points were as follows: a) points were placed 
on vertices along the body outline (inseam, underarms, elbows, etc), b) additional 3-
point sets were used to capture major body contours (thighs, shoulders, neck etc.) 
defining the start, apex, and end of the contour, and c) point locations were picked that 
were easily visualized such that their placement was accurate and precise across the 
sample. The 50 points chosen were considered to be the minimum number of points 
that satisfied these criteria, but an alternative number of points was not tested at this 
time. The ASM of the silhouettes was built using the active shape modeling toolkit 
(Visual Automation Limited, Manchester, U.K.), a software program that generates 
image parameters based on principal component analysis of fiducial markers on 
images, the details of which can be found in Gregory et al.[103] and Cootes et al.[102] 
In brief, the 50 points were manually placed on the first few images. Then, the software 
used these initial placements to build a limited ASM. With this limited ASM, the software 
predicted the placement of the points in subsequent images. All points were manually 
reviewed and adjusted as necessary. This process was repeated, i.e. initial placement 
by the limited ASM, manual inspection, then the rebuilding of the ASM, for every 10 
images analyzed until all of the images were added to the model. 
From the dataset formed from the point positions of all 50 points on all images, 
modes of variation were generated using principal component analysis. The result was 
a model that described the unique modes of variation in the form of a set of 
eigenvectors (i.e. modes of variation) where each successive eigenvector explains less 
of the variation than the previous. By combining the average point placements with the 
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linear combinations of the eigenvector basis, the location of the fiducial markers for any 
particular image can be generated. The coefficients that are used in the linear 
combination (i.e., how much each eigenvector is scaled) are the output parameters of 
each image. These output parameters were used for statistical analysis. It is convenient 
to visualize principal components in this context by generating series of shape images 
in which a single principal component is varied while all others are held fixed at their 
average value. Such images are shown in Figure 5.3. In each row, the middle image is 
the overall “average shape” generated from the test data set. Extreme images are 
generated by varying the principal component of interest to its +3 and -3 standard 
deviation values and combining with the average image. These extreme images are 
shown on the left and right of the average image. For example, it is readily apparent that 
PCA Mode 1 (pc1) captures shape information related to body width and height.  
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 Figure 5.3. Silhouette representations of the first 10 (i.e. 0 to 9) modes used to model FFMI in both boys and girls. The 
average silhouette is shown in the middle and the silhouettes representing -3SD (left) and +3SD (right) are also shown.  
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Statistics 
All statistics were performed in SAS version 9.3 (SAS Institute, Cary, NC). The 
BMDCS study population was separated into two groups by sex. FFMI was defined as 
௅௘௔௡ ௦௢௙௧ ௧௜௦௦௨௘ ௠௔௦௦ା஻ெ஼
௛௘௜௚௛௧మ  𝑘𝑔/𝑚ଶ where BMC = bone mineral content, FMI was defined as 
ி௔௧ ௠௔௦௦
௛௘௜௚௛௧మ  𝑘𝑔/𝑚ଶ, and percent fat was defined as 
ி௔௧ ௠௔௦௦
௧௢௧௔௟ ௠௔௦௦ ∗ 100 . Note that BMI = FMI + 
FFMI using these definitions. The ASM parameters of each silhouette (i.e., the 
coefficients of the eigenvector basis) were placed in a matrix, with each column 
corresponding to the principal component number and each row the silhouette number 
corresponding to each of the children.  
Limiting our analysis to the components needed to describe 95% of the image variation, 
step-wise linear regression with n-fold (leave-one-out) cross-validation (GLMSELECT 
procedure in SAS) was used to generate a predictive model for FFMI, FMI, and percent 
body fat. Separate model equations were made from both PCA components and 
demographic variables. A cross-validation stop criterion was defined on the Schwarz 
Bayesian criterion (SBC). Statistical significance was defined as the p < 0.05 threshold. 
The final models for FFMI, FMI, and percent body fat were generated using three 
different approaches. As a reference point, we first derive prediction equations using 
demographic variables only (age, sex, height, weight, BMIZ). We compared these to 
equations derived using principal components only. Finally, we combined principal 
components and demographic variables.  
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Results 
 
In a total of 200 participants, 11 were excluded during quality control for reasons 
including movement and poor positioning. Of the remaining 189 participants, 93 were 
male. The children were mainly white (112) but also include Asian (8), Hispanic (24), 
and Black (45). Summary statistics about the selected test population are provided in 
Table 5.1. Twenty-six principal components were required to explain 95% of the variance 
in silhouette shapes. All subsequent analysis was limited to these 26 components.  
Table 5.2 shows the correlations between the principal components, 
demographic, and adiposity measures. Several of the components (e.g., pc0, pc1 and 
pc5) showed significant correlation with multiple demographic and adiposity variables. 
Additionally, a few components (e.g. pc9 ) were not found to be significantly correlated 
with any demographic or adiposity variables. It can be seen in Figure 5.3 that pc9 
appears to capture a variance in positioning of the left shoulder, a “tilt” along the 
longitudinal-axis, irrelevant to our analyses. Other patient positioning artifacts such as 
arm and leg abduction/adduction can be observed in several of the other principal 
components. 
Table 5.1. Summary statistics of the test population separated by sex. 
Demographic  
Variable 
Girls (n = 96)     Boys (n = 93) 
Mean  Std. Dev.  Min  Max     Mean (SD)  Std. Dev.  Min  Max 
Age (years)  10.3  3  6  16     10.5  3.2  6  16 
Height (cm)  141.2  15.5  108  173     144.6  19.3  111  185 
Weight (kg)  38.9  14.9  17.2  81.8     40.9  17.7  18.1  87.4 
BMI (kg/m2)  18.8  3.8  13.3  30.1     18.6  3.5  13.7  28.8 
BMIZ  0.4  0.9  ‐1.8  1.9     0.3  1  ‐2  1.9 
FMI (kg/m2)  5  2.1  2.1  10.4     3.9  1.7  1.7  10 
FFMI (kg/m2)  13.3  2.1  10.4  20.3     14.2  2.6  10.5  21.6 
Percent Body 
Fat  25.5  6.1  14.3  39.3     20.4  6  9.7  38.1 
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The body composition prediction equations for boys and girls are shown in Table 
5.3 and Table 5.4, respectively. In general, the demographic information only had a 
modest ability to predict percent body fat in boys and girls (R2 = 0.457 and 0.61 
respectively.) Using only principal components to predict % Fat was also modestly 
correlated (0.73 and 0.59 respectively.) For % Fat, a combination of demographics and 
principal components created the best models (0.75 and 0.69 respectively). For the 
boys, the equation (omitted) for %fat (PCA+demo) included two additional PC terms 
(PC3 and 13) but no demographic variables. These coefficients remained due to the 
progression of the stepwise selection algorithm and were interpreted as artifacts. 
 For all measures of FFMI, FMI, and percent body fat, the combination of 
principal components with demographics performed equally or better than either 
principal components alone or demographics alone. No conclusion can be drawn 
whether the principal components alone fare better or worse than the demographics 
alone. They performed about equally well for % Fat and FMI in girls (Table 5.4) but the 
principal component alone model performed better for % Fat and FMI in boys (Table 
5.3), while the demographics-only model had a slight advantage in FFMI prediction. 
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Regression plots of the best models versus the actual measures are shown in Figure 
5.4.  
Table 5.2. Correlation of the most significant principal components with demographic and adiposity variables (R2). 
Principal 
Comp. # 
Age  Height  Weight  BMI z‐score  %Fat  FFMI  FMI 
Boys  Girls  Boys  Girls  Boys  Girls  Boys  Girls  Boys  Girls  Boys  Girls  Boys  Girls 
pc0  0.659‡  0.479‡  0.688‡  0.469‡  0.784‡  0.700‡  0.615‡  0.698‡  0.364‡  0.647‡  0.716‡  0.695‡  0.622‡  0.780‡ 
pc1  0.534‡  0.454‡  0.544‡  0.510‡  0.339‡  0.243*  ‐0.284†  ‐0.374‡  ‐0.173  ‐0.286†  0.137  0.105  ‐0.100  ‐0.180 
pc2  0.183  0.094  0.210*  0.147  0.170  0.090  0.105  0.000  ‐0.083  0.051  0.175  0.035  0.023  0.055 
pc3  0.069  ‐0.098  0.081  ‐0.082  0.116  0.034  0.117  0.316†  0.033  0.266†  0.124  0.065  0.070  0.224* 
pc4  ‐0.261*  ‐0.189  ‐0.244*  ‐0.196  ‐0.179  ‐0.055  0.218*  0.249  0.456‡  0.166  ‐0.234*  0.020  0.337†  0.154 
pc5  ‐0.028  0.352‡  0.014  0.307†  0.079  0.388‡  0.228*  0.204*  0.217*  0.193  0.083  0.350†  0.265*  0.300† 
pc6  ‐0.165  0.0003  ‐0.224*  ‐0.064  ‐0.103  0.108  0.195  0.186  0.278†  0.112  ‐0.059  0.173  0.258*  0.169 
pc7  ‐0.118  ‐0.176  ‐0.097  ‐0.149  ‐0.183  ‐0.108  ‐0.099  0.029  ‐0.004  0.031  ‐0.219*  ‐0.101  ‐0.085  ‐0.024 
pc8  ‐0.019  ‐0.170  ‐0.039  ‐0.230*  0.009  ‐0.174  0.020  0.008  ‐0.022  ‐0.011  0.035  ‐0.132  ‐0.016  ‐0.061 
pc9  ‐0.091  0.080  ‐0.119  ‐0.042  ‐0.086  ‐0.013  ‐0.009  ‐0.037  0.106  0.051  ‐0.073  ‐0.023  0.078  0.024 
pc10  0.152  0.178  0.165  0.219*  0.268†  0.133  0.376‡  ‐0.016  0.319†  0.127  0.260*  0.000  0.413‡  0.110 
pc11  0.131  0.074  0.107  0.096  0.084  0.062  ‐0.048  0.054  ‐0.028  0.046  0.043  0.030  ‐0.021  0.016 
pc12  0.121  ‐0.165  0.141  ‐0.258*  0.154  ‐0.170  0.082  ‐0.078  ‐0.134  ‐0.169  0.184  ‐0.057  ‐0.059  ‐0.148 
pc13  ‐0.120  ‐0.111  ‐0.056  ‐0.114  ‐0.060  ‐0.151  ‐0.001  ‐0.124  0.273†  ‐0.107  ‐0.161  ‐0.140  0.206*  ‐0.148 
pc14  0.058  0.137  0.051  0.111  ‐0.006  0.130  ‐0.216*  0.021  ‐0.080  0.051  ‐0.071  0.109  ‐0.104  0.096 
pc15  0.046  0.294†  ‐0.015  0.204*  0.009  0.195  0.070  ‐0.039  ‐0.060  ‐0.117  0.071  0.224*  ‐0.041  ‐0.011 
pc16  0.319†  0.164  0.335†  0.157  0.335†  0.111  0.0488  ‐0.039  ‐0.288†  ‐0.158  0.375†  0.141  ‐0.130  ‐0.069 
pc17  ‐0.130  0.035  ‐0.142  0.119  ‐0.217*  0.133  ‐0.278†  0.095  ‐0.043  ‐0.047  ‐0.250*  0.171  ‐0.096  0.046 
pc18  ‐0.044  ‐0.015  ‐0.050  0.072  ‐0.077  0.004  ‐0.058  0.039  0.005  0.022  ‐0.078  ‐0.034  ‐0.044  ‐0.015 
pc19  0.215*  ‐0.154  0.142  ‐0.169  0.155  ‐0.116  0.090  ‐0.074  ‐0.205*  ‐0.111  0.265*  ‐0.053  ‐0.065  ‐0.075 
pc20  ‐0.059  0.086  ‐0.078  0.093  ‐0.053  0.142  ‐0.180  0.017  ‐0.018  0.098  ‐0.097  0.112  ‐0.017  0.160 
pc21  ‐0.029  0.007  ‐0.055  0.086  ‐0.067  0.056  ‐0.077  0.082  0.090  ‐0.027  ‐0.110  0.055  0.040  ‐0.015 
pc22  0.104  0.036  0.032  0.057  0.025  0.023  ‐0.024  0.012  0.094  0.043  ‐0.020  ‐0.007  0.113  0.008 
pc23  ‐0.123  0.232*  ‐0.153  0.163  ‐0.111  0.183  0.095  0.130  ‐0.067  0.019  ‐0.011  0.256*  ‐0.067  0.086 
pc24  ‐0.129  ‐0.076  ‐0.135  ‐0.079  ‐0.188  ‐0.043  ‐0.176  0.096  ‐0.230*  0.110  ‐0.139  ‐0.045  ‐0.275†  0.070 
pc25  ‐0.073  ‐0.120  ‐0.067  ‐0.092  ‐0.078  ‐0.177  0.015  ‐0.146  0.056  ‐0.170  ‐0.080  ‐0.176  0.025  ‐0.191 
pc26  ‐0.069  0.136  ‐0.059  0.169  ‐0.009  0.062  0.099  ‐0.147  0.052  ‐0.093  0.024  ‐0.031  0.069  ‐0.075 
* indicates p<0.05, † indicates p<0.01, ‡ indicates p<0.001 
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Table 5.3 Prediction equations, R2 adj. (see definition below table), and root-mean-square error (RMSE), for 
demographic variables, FFMI, FMI and Percent Fat from PCA modes and demographic information using the 
boys’ data.  
Variable (method)   Boys Prediction equation  R2adj  RMSE 
% Fat (demo)  ‐94.943 + 1.761*height ‐ 0.007*height2 + 0.44*weight + 1.421*BMIZ  0.457  4.411 
% Fat (PCA)  21.818 + 13.218*pc0 ‐ 6.225*pc1 + 21.929*pc4 + 17.214*pc5 + 14.52*pc6 + 30.348*pc10 ‐ 28.108*pc12 ‐ 49.375*pc16 ‐ 42.53*pc19 + 32.767*pc21  0.728  3.119 
% Fat (PCA + demo)  (no demographic variables added significantly to the model)     
     
FMI (demo)  3.523 + 1.266*BMIZ  0.519  1.186 
FMI (PCA)  4.291 + 6.025*pc0 ‐ 1.461*pc1 + 2.45*pc3 + 4.989*pc4 + 6.007*pc5 + 4.508*pc6 ‐ 2.237*pc8 + 8.5*pc10 ‐ 5.873*pc12 ‐ 8.393*pc16 ‐ 6.109*pc19 + 7.043*pc21  0.861  0.637 
FMI (PCA+demo)  (no demographic variables added significantly to the model)     
     
FFMI (demo)  14.979 ‐ 0.061*height + 0.197*weight  0.884  0.875 
FFMI (PCA)  14.043 + 8.538*pc0 + 1.792*pc2 + 3.204*pc3 ‐ 3.863*pc4 + 5.034*pc5 ‐ 5.954*pc7 + 6.664*pc12 ‐ 12.616*pc13 + 17.425*pc16 ‐ 10.531*pc17 + 13.946*pc19 ‐ 9.234*pc21  0.822  1.084 
FFMI (PCA + demo)  14.093 ‐ 3.536*pc4 ‐ 3.335*pc10 + 4.013*pc12 ‐ 5.218*pc13 + 7.87*pc16 + 7.814*pc19 ‐ 5.581*pc21 + 0.176*age ‐ 0.05*height + 0.126*weight + 0.692*BMIZ  0.946  0.599 
demo: R2 and RMSE were calculated using only demographic variables 
PCA: R2 and RMSE were calculated using only the PCA coefficients derived from the active shape model 
PCA + demo: R2 and RMSE were calculated using both PCA & demo. 
R2 adj: the coefficient of determination adjusted for the number of parameters used in the model equation.
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Table 5.4. Prediction equations, R2 adj. (see definition below table), and root-mean-square error (RMSE), for 
demographic variables, FFMI, FMI and Percent Fat from PCA modes and demographic information using the 
girls’ data.  
Variable (method)  Girls Prediction equation  R2adj  RMSE 
% Fat (demo)  23.586 + 5.257*BMIZ  0.606  3.830 
% Fat (PCA)  24.998 + 17.594*pc0 ‐ 7.372*pc1 + 11.857*pc3 + 18.405*pc5 + 19.104*pc10  0.586  3.926 
% Fat (PCA + demo)  23.577 + 7.099*pc0 + 19.925*pc10 ‐ 18.239*pc15 ‐ 21.687*pc16 ‐ 32.043*pc17 + 4.111*BMIZ  0.691  3.392 
     
FMI (demo)  4.217 ‐ 0.0002422*height2 + 0.137*weight + 0.913*BMIZ  0.851  0.795 
FMI (PCA)  4.766 + 7.609*pc0 ‐ 1.022*pc1 + 2.038*pc2 + 3.375*pc3 + 2.599*pc4 + 7.732*pc5 + 6.181*pc6 + 8.311*pc10 ‐ 5.523*pc13 ‐ 5.651*pc17  0.886  0.694 
FMI (PCA+demo)  5.19 + 1.43*pc0 + 5.079*pc10 ‐ 3.931*pc12 ‐ 4.834*pc15 ‐ 4.907*pc16 ‐ 6.405*pc17 ‐ 5.28*pc19 ‐ 0.00032333*height2 + 0.153*weight + 0.586*BMIZ  0.895  0.667 
     
FFMI (demo)  10.767 + 0.165*age ‐ 0.00029077*height2 + 0.173*weight  0.881  0.712 
FFMI (PCA)  13.288 + 6.962*pc0 + 1.807*pc1 + 2.258*pc2 + 8.859*pc5 + 4.099*pc6 + 9.11*pc15 + 9.64*pc16  0.732  1.069 
FFMI (PCA + demo)  10.649 ‐ 3.135*pc10 + 5.363*pc17 + 0.192*age ‐ 0.00028224*height2 + 0.166*weight  0.892  0.679 
demo: R2 and RMSE were calculated using only demographic variables 
PCA: R2 and RMSE were calculated using only the PCA coefficients derived from the active shape model 
PCA + demo: R2 and RMSE were calculated using both PCA & demo. 
R2 adj: the coefficient of determination adjusted for the number of parameters used in the model equation. 
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Figure 5.4. Comparison between FMI (top), FFMI (middle), and percent fat (bottom) values acquired from DXA 
scans and predicted by the PCA models constructed from silhouettes with boys (left) and girls (right). The 
associated R2 adj. values are found in Table 3 and 4. 
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Discussion 
In this study, we evaluated the possibility of using silhouettes, or whole body 
shadow images, to estimate fat and lean body composition indices. We found that the 
addition of the shape descriptors in the form of principal components did improve on the 
estimates of body composition over a demographics-alone model for both boys and 
girls. Additionally, the demographics-only and the PCA-only models had comparable R2 
adj. and RMSE, with the exception of girls’ FFMI. Even though these silhouettes were 
made from DXA whole-body scans, this study suggests that shadow imaging using 
simpler optical imaging devices, such as simple cell phone cameras, could be used to 
generate similar silhouettes and associations to body composition. To our knowledge, 
this is the first study of its kind to show that the shape of silhouettes can be used to 
quantify body composition measures. 
Clearly, some principal components generated by our analysis were related to 
the positioning of the individual. DXA whole-body scans are acquired with standardized 
positioning, but the standardization was not intended for direct image registration. It 
would easily be possible to eliminate many of the positioning variation modes (leg 
abduction/adduction, torso twisting, arm raising, etc.) if the DXA scans were acquired 
with this detail in mind. Likewise, for an optical acquisition protocol, positioning of the 
arms and legs could be more tightly controlled to reduce the contribution of positioning 
to the overall total variation or omitted if it is found that they provide little to no benefit in 
the model. In DXA scans, there is a tendency to not repeat a scan if there are minor 
positioning issues because of radiation exposure.  
This study was a pilot demonstration and not intended to be a final model since, 
ultimately, it is not useful to use DXA images as the primary data source for silhouettes. 
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Silhouette models should be derived for a specific imaging technology, since 
magnification and projection differences may change the presentation of the silhouette. 
The silhouettes used in this study were low spatial resolution compared to cell phone 
cameras. The DXA-based silhouette images were created with a maximum of 21,800 
pixels (1.0 x 6.5 mm2 pixel size), or in common camera terminology, the equivalent to a 
0.022 megapixel resolution. This resolution is worse than that of the cheapest 640x480 
(i.e. 0.31 Megapixel) cell-phone camera. Most current cell phones have cameras with 
resolution of 1 megapixels or above. Besides spatial resolution, one must also consider 
the pose (position + orientation) of subjects, their clothing, and the imaging background. 
These three factors require standardization for optical imaging as it was for the DXA 
imaging to create a successful ASM. For optical imaging, clothing would have to be 
thinly layered and fit snugly so as to not significantly alter patients’ body outline. In 
addition, patients should be optically imaged using standardized anatomical positioning 
to minimize the variance unrelated to body composition (as seen in some of the PCA 
modes). Unlike DXA, repositioning and re-imaging could be performed repeatedly until 
an ideal image is acquired. The distance between the imaging plane and the camera 
would also need to be equivalent across all images. To adjust for differences in optical 
characteristics of different cameras, a calibration object of known dimensions (e.g. a 
meter stick or piece of letter-size paper) may be placed coplanar with the subject. Post-
acquisition scaling can then be performed to normalize pixel dimensions. Lastly, a 
“green screen” technique could be used to insure the removal of background was 
consistent. Given that the above mentioned factors are mitigated, cell phone images 
should perform equally or better than DXA images for generating silhouettes. The 
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optical extension of this study could be useful in clinical applications, low resource 
settings (e.g., point-of-care centers) or when traveling with light equipment is desired 
(e.g., visiting patients’ homes to acquire adiposity measurements). Three-dimensional 
optical images, such as available from the Microsoft Kinect[104], may be advantageous 
to 2D images in that they collect more detail on body curvature, especially that 
curvature that cannot be seen in a silhouette. The strengths and limitations of 2D versus 
3D approaches for fitness and nutritional assessment have yet to be explored. 
This study had several limitations. First, the participants were imaged in a supine 
position. We envision that the practical application will use a standing position. Body 
shape will be different for standing versus supine, but all the concepts derived here 
should be just as applicable. There is the possibility of over-fitting, given the number of 
variables included in our models. To address this, we used a cross-validation (leave one 
out) approach. Ideally, future validations of the optical imaging approach should use 
separate populations. Additionally, we did not address body shape difference by 
ethnicity. The sample size for each ethnicity was small. A larger and more diverse 
sample (separated into ethnicities) will be used in future studies to determine if there are 
unique body shapes by ethnicity. 
We have demonstrated the potential to derive FMI, FFMI, and percent fat 
estimates from whole body silhouettes that could be useful for the assessment of 
adiposity and muscularity. The technique presented here may be appropriate to apply to 
images acquired with simple cell-phone cameras.  
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Chapter 6 Future Directions 
 
The three-compartment breast technique is still in early development, though it 
has applications in other modalities as well. The concept of using a three-compartment 
model for tissue compositions can be applied in dual-energy computed tomography and 
magnetic resonance imaging as well. There have already been applications in CT by 
Ding et al.[105-107] Since CT has a sweep angle of 180°, the total thickness can be 
computed easily without any external phantoms. Their studies have shown that it is 
feasible to apply the 3CB technique to CT. In MRI, the total thickness can also be easily 
computed, since MRI is also a 3D imaging modality. In addition, chemical composition is 
already possible with MRI, so water, lipid, and protein signatures can be estimated. 3CB 
can also be implemented in digital breast tomosynthesis, and preliminary work has been 
done in this thesis. If it is shown possible to obtain accurate breast thickness estimates 
from tomosynthesis projections, one would still need to consider performing 𝐼଴ 
corrections, however.  
As shown, one limitation of the 3CB technique is how prone it is to errors. It 
would be valuable to assess the detectability of lesions using the 3CB technique. For X-
ray applications, a contrast detail mammography (CDMAM) phantom made from 3CB 
materials could elucidate 3CB limits. In addition, a separate CDMAM phantom made 
from biological materials would be even more informative, though precise manufacturing 
of such a phantom could be impractical.  
Recently, investigations combining the 3CB technique and quantitative imaging 
have revealed promising results for discriminating between benign and malignant 
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legions during diagnostic imaging. The positive predictive value (PPV) was 32.1% (35 of 
109; 95% CI: 23.9% - 41.3%) with a sensitivity of 100% for diagnostic digital 
mammography and 49% (34 of 70; 95% CI: 36.5% - 58.9%; p < .001) with a sensitivity 
of 97% and 35.8% (39 of 109) fewer total biopsies (p < .001)for combined 
mammography radiomics plus quantitative 3CB image analysis. Further developments 
could lead to lowering unnecessary breast biopsies.[108] 
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Chapter 7 Conclusions 
 
The work in this dissertation focused on further developing the three-
compartment breast composition technique, initially developed by Laidevant et al. in Dr. 
John Shepherd’s Lab, for use in clinical practice. Major efforts were made in correcting 
sources of error, which initially had impractical compositional thickness estimates. 
Another major task was to do initial developments for 3CB applications in digital breast 
tomosynthesis. Lastly, a novel technique for measuring body composition from 2D 
optical images to help monitor and maintain healthy body weight was covered. The 
conclusions for each of these works are summarized here. 
Three major sources of error were discovered that made the 3CB technique 
susceptible to incorrect compositional estimates. All three error sources have direct ties 
to minimizing differences between patient and calibration images; that is, all three 
sources should be corrected according to specific energies at which 3CB images are 
acquired. Attenuation coefficient differences in biological materials—for which 3CB is 
estimating compositional estimates—and their calibration equivalents relied on creating 
linear mappings between material spaces with bovine and chicken phantoms at specific 
kVps. Secondly, an empirical flat-fielding model was created to remove nonuniformities 
in FFDM from X-ray source spectra, making it so that 𝐼଴ would be position-independent 
along the detector plane. Thirdly, both 𝐼଴ correction models made it possible to obtain 
similar log-signal values between breast and calibration images, and both were made 
for specific kVps. Energy-based errors seemed to have limited the 3CB technique from 
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becoming clinically practical in FFDM, and efforts should be made to minimize 
differences between all patient and calibration imaging conditions.  
To make the 3CB applicable to DBT, two areas were investigated. Firstly, dose 
measurements and estimates were made for HE 3CB DBT images. It was found that a 
copper filter of 0.4064 mm (16 mils) seems to be optimal in terms of meeting dose 
requirements, availability, and CNR. In addition, imaging at 71 mAs seems to optimize 
CNR while satisfying dose requirements. Secondly, investigations sought to derive 
potential variables of interest as predictors of breast thickness from raw DBT 
projections. It was found that variables derived from sinograms could be potentially 
useful in estimating breast thickness from raw DBT projections. Though these two 
efforts have advanced 3CB DBT, there still remain many challenges. Indeed, many 
efforts will most likely focus on minimizing differences between patient and calibration 
images.  
The last topic discussed in this thesis focused on developing a novel body 
composition technique from optical images. This proof-of-concept study showed that it 
may be possible to determine fat mass index, fat-free mass index, and percent-fat from 
2D optical images. For breast cancer applications, this could aid in monitoring adipose 
and muscular tissues to monitor and maintain a lean weight to reduce risk of cancer for 
postmenopausal women.  
In Summary, two of the three major works in this study advanced the 3CB 
imaging technique to become more clinically practical in dual-energy absorptiometry 
applications. The last focus of this thesis may make it easier to monitor body 
composition in low-resource settings. 
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Appendix A: Code Availability 
Several software tools and analysis scripts were developed over the course of 
this dissertation. These pieces of code are maintained in secure repositories on the 
Shepherd Lab GitHub (https://github.com/shepherd-lab). A listing of relevant 
repositories is provided below. Please direct inquiries to Jesus Avila 
(jiavila@berkeley.edu) or John Shepherd (johnshep@hawaii.edu). 
 3CB Repository (https://github.com/shepherd-lab/3c_sxa) 
o MATLAB scripts for automatic processing and reprocessing of 3CB 
patients for estimating water, lipid, and protein thicknesses of breast 
lesions annotated by radiologists. 
o ASTRA Toolbox scripts in MATLAB for simulating and estimating breast 
thickness
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